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ABSTRACT
Intro:
Anxiety is often a chronic condition that will affect approximately 29% of
individuals during their lifetimes (Dennis & O’Toole, 2014). Unfortunately, numerous
barriers to treatment exist, especially when treating children (Dennis & O’Toole, 2014).
Wearable technology, particularly utilizing heart rate monitoring, can potentially aid in
the treatment of anxiety, allowing for greater recognition of symptoms and interventions
in any setting.
Hypothesis:
Hypothesis one: College students with "mild to moderate" levels of anxiety will
be able to utilize self-monitoring heart rate biofeedback (SMHRB) consistently (e.g.,
respond to at least 70% of Maximum HR alerts utilizing relaxation breathing).
Hypothesis two: participants who consistently implement relaxation breathing in
response to a Maximum HR alert will significantly reduce symptoms of anxiety from
baseline levels on a global anxiety scale.
Methods:
A series of individual AB designs were used with random assignment to baseline
phases to track 7 participants on a global measure of anxiety (CUXOS). Participants with
mild to moderate anxiety were measured in pre-baseline, baseline, and intervention
phases to examine change due to the self-monitoring heart rate biofeedback intervention.
After the baseline phases were completed, participants were trained to use the wrist-worn
heart rate monitor to assist with the identification and remediation of symptoms of
anxiety. In addition to reporting their weekly CUXOS score through a Google Form via a
text message, participants also reported usage information two times daily.

Results:
The intervention was considered Effective for four out of seven participants (57%), while
it was considered Ineffective for two out of seven (29%) and Minimally Effective for one
out of seven (14%). The 4/7 participants who responded well to treatment showed an
average reduction on the CUXOS of 15 points. Moreover, most participants (5/7)
showed a favorable increase in HRV, which also corresponded to a decrease in CUXOS
scores. All seven participants reported the intervention was easy to use, helpful, and that
they would continue to use a version of it in the future. However, four out of seven
participants stated they had some trouble with the device initially, and three participants
noted that the flashing red light (HR alert) sometimes contributed to anxiety. In the
reporting of usage information, just under half of all twice daily text message data was
submitted by participants on average. This usage data revealed that participants reported
wearing the device 90 % of the time during their intervention periods. Of all the heart rate
alerts participants received, 37% of them corresponded with subjective feelings of
anxiety. Participants intervened with anxiety using the intervention 83% of the indicated
times.
Conclusion:
Wearable biofeedback interventions may be promising. However, key design features are
essential to consider for future research. The ideal design for future research would
include using a device compatible with automatic collection of usage and biofeedback
data and the use of multiple control groups to verify effective components of an
intervention. Lastly, improving the correlation between physiological measures such as
heart rate alerts and subjective emotional states is essential. Improving the accuracy of

devices may be accomplished through the use of more complex alert measures such as
HRV instead of HR. Alternatively, an extended reporting period, whereby users allow
HR measures to become more reliable and provide feedback to researchers in order to
select a more accurate beats per minute (BPM) threshold that indicates increased anxiety,
could be promising
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Chapter 1:
Summary Statement of the Problem and Overview
It is estimated that 32 % of adolescents will be diagnosed with an anxiety
disorder at one time in their lives (Merikangas et al., 2010). Furthermore, 22% of
adolescents may be suffering from anxiety during a one-year period, which amounts to
approximately 13.4 million adolescents in the United States (NIMH, Harvard National
Comorbidity Study, 2017). Untreated, anxiety disorders can impair a person’s ability to
learn, self-regulate, and can severely affect their relationships (Beesdo, Knappe, & Pine,
2009). For a variety of reasons, up to 80% of adolescents with an anxiety disorder do not
receive treatment (Taras et al., 2004). Recently, self-monitoring and biofeedback have
been used to support relaxation and aid in the reduction of the body's sympathetic
nervous system responses to anxiety-provoking stimuli (Prinsloo, Derman, Lambert, &
Rauch, 2013). Although there is evidence supporting the use of self-monitoring and
biofeedback in the treatment of anxiety, few if any studies have examined the
effectiveness of using wearable biofeedback devices for the management of anxiety in
natural environments such as an educational setting. Adolescents spend a majority of
their time in educational settings; thus, exploring treatment options that are compatible
with these settings is essential to improvements in treatment. New technology has made
heart rate biofeedback more available, comfortable, convenient, and even fashionable.
Although this technology has developed rapidly in recent years, there is a need for more
studies examining its use and effectiveness, particularly with youth in schools.
Two central research questions have been investigated in this research study.
Research question one sought to determine: to what extent adolescents with symptoms of
1

anxiety utilize the self-monitoring heart rate biofeedback (SMHRB) intervention
consistently? Within the scope of the first research question, there was an examination of
information pertaining to how the intervention (independent variable (IV)) was applied.
For example: a) how often did students respond to a HR alert and initiate relaxation
breathing, or recognize the alert but not initiate any intervention at all; b) how often did
students use relaxation breathing without a maximum HR alert; c) how often did the alert
not correlate with subjective self-assessment of anxiety? Participants responded to a
Google Form that (submitted via text message, twice daily) provided information about
the independent variable in order to substantiate how it was being used.
Research question two addressed the effectiveness of the intervention in reducing
symptoms of anxiety as measured by a global anxiety measure, the Clinically Useful
Anxiety Outcome Measure (CUXOS).
Hypothesis one: College students with "mild to moderate" levels of anxiety will
be able to utilize self-monitoring heart rate biofeedback (SMHRB) consistently (e.g.,
respond to at least 70% of maximum HR alerts utilizing relaxation breathing). Hypothesis
two: participants who consistently implement relaxation breathing in response to a
Maximum HR alert will significantly reduce symptoms of anxiety from baseline levels on
a global anxiety scale.
Background and Justification of the Study
New technologies and innovations are offering treatment alternatives that utilize
wearable technology, biofeedback, and smartphones. The ubiquity, availability, and
cross-cultural acceptance of these interventions allow them to traverse traditional barriers
to treatment such as cost, accessibility, time commitment and negative stigma (Dennis &
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O’Toole, 2014). SMHRB could be a tool that allows users with moderate symptoms of
anxiety to effectively intervene in a manner that reduces these traditional barriers, and
could be used as an effective adjunct to more traditional therapy. This research centers
on symptoms of anxiety, particularly focusing on reducing the specific symptom of
increased heart rate in response to stress. Furthermore, a description of the integrated
components of SMHRB are included. Together, these integrated components offer
promise for a reduction in symptoms of anxiety. The research will also offer a rationale
for why there is a need for an effective, portable, on-demand intervention for symptoms
of anxiety.
Significance of anxiety. Anxiety disorders are the most prevalent of all
psychological disorders (Beesdo, Knappe, & Pine, 2009). Anxiety is characterized by
chronic symptoms of persistent worry (Parker, 2015) and can manifest with a variety of
physical and emotional symptoms (Goldberg, 2014). Evidence suggests that those with
the condition are at an increased risk for developing other chronic medical conditions,
suffer more severe medical symptoms, and have a higher mortality rate (Parker, 2015).
Anxiety also can interfere with the ability to regulate thoughts, actions, and
emotions. These thought disruptions are particularly concerning for adolescents in
secondary and postsecondary educational settings. The relationship between poor test
performance and anxiety is well-documented. However, less apparent is that anxiety can
have a significant impact on education as a whole. Specifically, anxiety may disrupt the
short-term memory involved in learning. Moreover, there is evidence to suggest that
chronic stress during key developmental periods can change brain structures
permanently, thus impairing future learning, behavior, and health (Shonkoff et al., 2011).
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Theoretical models of anxiety and the connection to HR. There are multiple
theories related to heart rate and the etiology and treatment of anxiety. One prevalent
theory describes the etiology of anxiety as inherited in and manifested in childhood
temperament and heart rate variability (HRV) (Ratanasiripong et al., 2004). There are
other theoretical models that describe the relationship between physiology and
psychological functioning. For example, the neurovisceral model of anxiety describes a
relationship between the cognitions involved in regulating anxiety and the autonomic
response. Additionally, the polyvagal theory describes the relationship between deliberate
actions by the individual that result in changes in biological states, such as relaxation
breathing and relaxation efforts (Quintanna et al., 2012). (See Literature Review in
Appendix A for a more in-depth review of biological theories related to stress.)
Impediments to treatment. A variety of impediments to quality treatment for
anxious youth include treatment costs, time commitment, accessibility (Dennis &
O’Toole, 2014), and issues with the acceptability of treatment (Herzig-Anderson et al.,
2012). The various obstacles to quality community-based treatment influence
approximately 70% of students diagnosed with anxiety to receive some support in
schools instead of clinical settings. Although schools offer advantages to obtaining
treatment, such as reduced transportation and family costs, in many cases schools are
overwhelmed and lack the resources to adequately support students who would benefit
most from obtaining treatment for anxiety (Herzig-Anderson et al., 2012; Taras et al.,
2004).
Self-monitoring
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Many technologies that allow for improvement in symptoms of anxiety utilize
some aspect of self-monitoring (SM). Self-monitoring is the act of measuring one's
behavior (target) and comparing it to an external standard or goal that can result in lasting
improvements to that behavior (Kazdin, 1989).
SM permits students to track their mental states independently, and improvements
in behavioral outcomes have been noted with SM without any additional intervention
(Shapiro & Cole, 1999). SM has been used to improve a variety of behaviors, including:
social skills, work completion, and self-regulating behaviors involved in anxiety.
Through self-monitoring, individuals can learn to recognize emotional states and to
identify and differentiate various emotions in different contexts (Kauer et al., 2012).
Increasing awareness of emotions is an essential step in training individuals to change
their cognitions, beliefs, schemas, and behaviors (Kauer et al., 2012; Walker & Shinn,
2002). Additionally, students who efficiently use processes such as self-monitoring
typically have higher levels of self-efficacy, motivation, and educational achievement
(Zimmerman, 2002).
Self-monitoring has shown utility as an intervention for internalizing disorders;
however, students often need assistance to initially begin to self-monitor their emotions,
thoughts, and behaviors (Flannery-Schroeder & Lamb, 2009). Technological devices may
offer a particular advantage for SM (Craske et al., 1999; Kauer et al., 2012), and Kauer et
al. report that tech-enhanced self-monitoring may increase emotional self-awareness
(ESA) and reduce symptoms of internalizing disorders.
Using a maximum heart rate alert function on a HR monitor could serve as a
prompt to initiate event recording as well as a prompt to initiate restorative behaviors
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aimed at self-regulation of emotion. The prompt may permit users to notice their
environment, circumstances, feelings, and emotions and then correlate them with HR.
The device may also have the capacity to assist in teaching students to recognize distress
directly and immediately employ self-regulation techniques to normalize heart rate,
emotions, and potentially reduce symptoms of anxiety.
The goal of SMHRB is for users to learn to identify their stress symptoms through
recognition of their physiological states and initiate relaxation breathing without outside
assistance. However, external prompting is an intermittent step that allows for scaffolding
between assisted and organic recognition and relaxation breathing. External prompting
may thereby increase the probability of users increasing their emotional and physical selfawareness in the future (Shapiro & Kratochwill, 2000). (See Appendix A Literature
Review for more information and previous research on self-monitoring.)
Although there is evidence supporting the use of HR and HRV biofeedback with
anxiety, few, if any, studies have examined the effectiveness of a HR biofeedback
intervention with anxious adolescents in their natural environment. Interventions using
biofeedback are increasing, and there is a need for more studies examining its use and
effectiveness, particularly with adolescents in educational settings. Determining whether
adolescents will consistently utilize heart rate self-monitoring with fidelity is important
and was a focus of this investigation. Moreover, if students do consistently utilize this
intervention, establishing how effective the intervention is in reducing anxiety will
provide valuable information to the ongoing development of treatments for this chronic
problem.
Research Questions and Hypothesis
6

Two central research questions were investigated. Research question one sought
to determine to what extent adolescents with symptoms of anxiety will consistently
utilize a SMHRB intervention? Within the scope of the first research question, there was
an examination of information pertaining to treatment fidelity, or how the intervention
(independent variable (IV)) was applied. For example, how often did participants: a)
respond to a HR alert and initiate relaxation breathing, or recognize the alert but not
initiate any intervention at all; b) how often did students use relaxation breathing without
a maximum HR alert; c) how often did the alert not correlate with subjective selfassessment of anxiety? Participants responded to a Google Form (submitted via text
message, twice daily) that provided information about the independent variable in order
to substantiate how it was being used.
Research question two addressed if the intervention was effective in reducing the
symptoms of anxiety as measured by a global anxiety measure, the Clinically Useful
Anxiety Outcome Scale (CUXOS).
Hypothesis one: College students with "mild to moderate" levels of anxiety will
be able to utilize self-monitoring heart rate biofeedback (SMHRB) consistently (e.g.,
respond to at least 75% of maximum HR alerts utilizing relaxation breathing). Hypothesis
two: participants who consistently implement relaxation breathing in response to a
Maximum HR alert will significantly reduce symptoms of anxiety from baseline levels on
a global anxiety scale.
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Chapter 2:
METHODOLOGY
Components of SMHRB
Self-monitoring is the first component of the SMHRB intervention. The act of
monitoring behavior and comparing it to an external standard has, in and of itself,
demonstrated improvement in the desired outcome behavior (Kazdin, 1989). A benefit of
self-monitoring is physiological self-awareness. Through practice with self-monitoring
heart rate, an increase in awareness of the relationship between emotional symptoms (i.e.,
fear, worry, stress) and physical symptoms (i.e., increased heart rate [HR]) of anxiety
may be possible. Self-monitoring through the use of a HR alert may improve
physiological self-awareness over time and allow a user to recognize and act on their
symptoms more frequently and more accurately over time. The second component of the
intervention is slow, relaxed breathing. Combining breathing with HR biofeedback may
potentially enhance the speed and degree of symptom relief. The combination of these
components of SMHRB was tested as one intervention with college students at the
University of Rhode Island using a series of individual AB designs. The research study
allowed for the collection of quantitative and some qualitative information on the
practicality, usability, and future potential of interventions utilizing SMHRB.
The current study utilized an intervention that incorporates self-monitoring and
heart rate biofeedback with symptoms of anxiety. This section begins with a description
of the participants involved and eligibility procedures. Next, tools and measures used in
the research are described. Finally, a description of the research design and timeline is
provided.
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Participants and Recruitment
After IRB approval was obtained, a convenience sample of seven URI
undergraduates was recruited. Recruitment was initiated through posting the IRB
approved flyer on social media sites accessible to students and through a General
Psychology course email. Students were free to participate without penalty or coercion
and could opt out at any time. Prior to obtaining informed consent, participants were
provided an in-depth description and full disclosure of procedures. Although unlikely, a
participant who did not see improvement could have become frustrated with their
participation. As such, students were made aware that they could opt for a referral for
counseling at any point during the study.
Inclusion criteria. Once recruited, students were administered the CUXOS
anxiety inventory and those who met the criteria of having “Mild to Moderate” symptoms
of anxiety, defined as a score between 21-40 on the Clinically Useful Anxiety Outcome
Scale (CUXOS), were considered eligible. Participants were required to be between the
age of 18-25; willing to communicate with the researcher by text message; and willing to
complete electronic surveys via Google Forms two times per day throughout their
participation in the study.
Exclusion Criteria. Students were administered a global screener, DSM-5 CrossCutting Symptom Measure (DSM-5 CCSM, in person, paper and pencil version: see
Appendix B for detailed administration instructions), to determine the potential for other
causal factors of distress besides symptoms of anxiety. The DSM-5 CCSM is a global
screening (level 1) measure that indicates whether participants should be screened further
for specific disorders. For example, while the screener has several disorder categories, if
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a participant endorses any question in a specific category (e.g., depression) on the global
(level 1) screener that indicates the potential presence of depression, then a more specific
(level 2) depression evaluation screening would be conducted. Participants who indicated
mild symptoms or higher on the second, more-specific disorder measure (level 2) would
have been extended a referral and excluded from the study (see Appendix B for
procedures for students with significant mental health concerns). Participants who
endorsed symptoms of a disorder (other than anxiety) on the first general level 1 screen
and did not indicate mild symptoms of the disorder on the more comprehensive level 2
screen were still eligible for the study. Once participants were administered the CUXOS
and DSM-5 CCSM, the items were scored immediately, and students knew of their
eligibility status prior to leaving the initial assessment meeting. Students were eligible if
they had not engaged in therapy or taken medication for anxiety for one year before the
study, or if they were not receiving pharmacotherapy or psychotherapy for anxiety during
the study. Furthermore, no student who was enrolled in classes taught by the researcher
participated in the study. Nine students were recruited and screened; two students were
found ineligible as they were already participating in treatment for anxiety with mental
health service providers. Seven participants remained part of the study for 9 weeks. They
were all students attending the University of Rhode Island, and were between the ages of
18 and 23. Two participants were male and five female.
Research Design
A series of seven individual AB designs were used for this research. Seven
participants were each randomly assigned to a baseline phase one, two, or three weeks.
This design allowed each participant's no treatment phase (BP) data to act as his/her own
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control for behavioral comparison with the intervention phase data. Once baseline phases
ended, the application of the experimental variable to a participant was expected to
produce a change when the intervention was employed (Barlow & Hersen, 1984).
Independent variables. The independent variables (IVs) in this study were
comprised of two components that make up the SMHRB intervention. The first is selfmonitoring of heart rate using a wearable electronic monitor, and the second is the use of
relaxation breathing techniques. These components were combined in the study and
theorized to more effectively reduce symptoms of anxiety than unaided self-monitoring
and breathing.
The relaxation breathing component (slow, relaxation breathing) was taught to
participants in individual meetings with the primary investigator. Participants were taught
a five-step method of slow, calm breathing (see Appendix C for detailed breathing
procedures). After mastering these breathing techniques, participants were taught to use
them in conjunction with increased heart rate alerts as indicated via the wearable device
described in the next section. Prior to entering into the intervention phase of the study,
each participant demonstrated the ability to reduce elevated heart rate by 5 beats per
minute as a function of using relaxation breathing.
Participants were also taught to use a wrist-worn heart rate monitor, the Mio
ALPHA 2. The HR monitor was used to alert participants, via a flashing red light, if and
when they had reached a predetermined max heart rate, indicating a potentially anxious
state. The alert was set for 5 BPM above the baseline resting heart rate obtained for each
participant (see Appendix B for detailed information on obtaining resting HR). 5 BPM is
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within the range observed as a typical spike while experiencing symptoms of anxiety
(Stewart, Buffett-Jerrott, & Kokaram., 2001).
Throughout each participant’s intervention phase, he/she was asked to wear the
device during their waking hours. Furthermore, they were instructed that, in the event of
a maximum HR alert that was accompanied by subjective feelings of anxiety, they should
begin slow relaxation breathing intended to reduce HR. For each HR alert and breathing
intervention episode, participants were instructed to discontinue relaxation breathing
when either they felt more relaxed or when their HR-BPM had been restored to a normal
range (close to their resting HR). Participants were asked to only engage in relaxation
breathing when they experienced feelings of discomfort (i.e. symptoms of anxiety.)
As a check on participant use of these intervention components, brief surveys
were administered via text message twice daily. These text messages included five short
questions, including: did you wear the monitor?; how many times did the monitor alert
you?; and how many times did you use the breathing techniques? (See Appendix E for a
complete list of daily questions.)
Dependent variables. The present study used two primary dependent variables to
measure symptoms of anxiety: one was utilized weekly while the other was used as a prepost measure only. The weekly measure, the Clinically Useful Anxiety Outcome Scale
(CUXOS), was administered to each participant in person during the eligibility meeting
and then via a text message link to a Google Form thereafter. The (CUXOS) consists of
20 questions focused on global symptoms of anxiety. It has been shown to be reliable and
valid based on multiple studies (See Appendix B for technical adequacy information).
A second dependent variable, heart rate variability (HRV), was measured in each
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participant at two points in time: once at the end of the baseline phase and once after the
conclusion of the intervention phase. HRV was obtained by using the Polar H10 HR
Monitor with chest strap. HRV is measured by analyzing the time between heartbeats.
Participants wear the chest strap monitor for approximately five minutes to detect HRV.
HRV was measured by using the average of the three, five-minute assessments as an
overall indicator of HRV. HRV has been shown to correlate with anxiety and has been
used consistently in a variety of studies as a measure of overall stress and psychological
functioning (Sharma, Balhara, Sagar, Deepak, & Mehta, 2011).
Timeline
Two groups of three participants began the study simultaneously in a nointervention baseline phase, and participants within each group were randomly assigned
to remain in baseline for differing lengths of time (one, two, or three weeks). Staggered
baselines allowed for comparisons both within and between participants, as well as
between intervention and baseline phases during the same time period, to allow for
observed behavior change to be attributed to the intervention (internal validity).
Arranging differing baseline lengths, and as a result having varied treatment lengths
allowed for more control and detection of historical events that may influence results. For
example, it is conceivable that participants may have an increase on the CUXOS during
one week due to a common factor such as midterm exams.
The study lasted nine weeks, with participants remaining in an intervention phase
for a minimum of six weeks. Participants’ time in the intervention phase ranged from six
to eight weeks depending on their randomly assigned baseline phase (one to three weeks).
For example, one week in BP resulted in eight weeks in the intervention phase.
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Participants were trained on the SMHRB intervention once their randomly assigned
baseline phase ended. This time frame is considered realistic for data collection based on
standards for interventions performed in education settings (Hixon, 2008). Additionally,
this time frame is consistent with other intervention timelines in other research with
anxiety and biofeedback (e.g., Houser et al., 2013). Also, McKee (2008) indicates that
biofeedback interventions start to show results of training generalization during this time
frame as well.
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Chapter 3:
RESULTS
This section is organized in the following manner. First, the overall data analytic
strategy is presented. Then, the results for each participant are presented, including
graphed quantitative data, fidelity of implementation (usage) data and a summary of
participant feedback in response to questions asked about the treatment. Next, an overall
summary of outcomes is provided followed by summary of all participant usage data.
Finally, a summary highlight of qualitative information obtained from participants openended questions is provided.
Data Analysis Strategy and Decision-Making Rubric
The categorical independent variable in this study was the intervention (SMHRB),
which was compared to a no-treatment baseline phase (BP) for each participant.
Descriptive statistics (e.g., percentage of HR monitor provided alerts that corresponded to
subjective anxiety) were used to estimate the accuracy of the HR alert as well as the
frequency and type of intervention the college student participants utilized (e.g.,
relaxation breathing, or no action). The dependent variables were the values obtained on
CUXOS and the HRV measure.
For each participant, five metrics were used to determine the effectiveness of the
intervention. Four metrics were based on CUXOS scores, and one metric was based on
the HRV measure. The metrics used were as follows: average weekly rating score change
during the intervention phase (i.e., slope of change over the time of the intervention);
percentage of nonoverlapping treatment phase data points between the lowest baseline
score and all of the treatment scores; overall quantitative change from last baseline point
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to last treatment point; categorical severity level change from the last baseline point to the
last treatment point; and change in HRV between the pre- and post-test assessment.
Table one provides a summary of the data analytic strategy for the evaluation of
obtained results.
Table 1.
Data Analysis Considerations in Evaluating Intervention Effectiveness
Method (Criteria)
(Metric)
CUXOS
Slope of
intervention
phase data.

CUXOS
Percentage of
Nonoverlapping
data points
(PND)

CUXOS
Quantitative
Change from
Baseline

CUXOS
Categorical
Severity Level
Change

Description

Example
Criterion “Met”

Non-Example
Criterion “Not
Met”

Mean weekly change for treatment was
calculated by using the formula (y1 - y2 / x1 x2) whereby the difference between the first
and last CUXOS treatment scores are divided
by the difference between the corresponding
treatment periods. This yields the average
weekly change in CUXOS points and this
criterion is required to be negative.
This metric identifies data of similar values
across baseline and treatment conditions. First,
the lowest baseline CUXOS score is identified.
Then the number of treatment phase CUXOS
scores falling below the lowest baseline score is
identified and calculated into a percentage of
total treatment phase scores. The criterion for
determining effectiveness is 50% or more of the
CUXOS treatment phase scores must be below
the lowest CUXOS baseline score.

Weekly Change
= -1.87

Weekly change
= .05

Participant’s
lowest CUXOS
baseline phase
score (30).
Treatment
scores =
28,24,28 32, 32,
26. 4/6 (67%) of
the treatment
scores are
below the
extreme
baseline score
(30).

This metric examines change in participant
level of anxiety according to the CUXOS
categorical system. A quantitative change
requires a decrease in score on the CUXOS of
at least 5 points between the last treatment
score and the last baseline score. 5 points is
roughly equal to ½ the distance between 2
levels (e.g. Moderate Anxiety. (31) - Mild
Anxiety. (21) Difference = 10).
A decrease in categorical level on the CUXOS
from the last baseline score to the last
treatment score.
Non anxious
0-10
Minimal anxiety 11-20
Mild anxiety
21-31
Moderate anxiety 31-41
Severe anxiety
41 and above

A participant
scored 40 on
their last BL
CUXOS phase
and 35 on their
last treatment
CUXOS.
Change of -5

Participant’s
lowest CUXOS
baseline phase
score (27).
Treatment
scores =
28,24,28 32,
32, 26. 2/6
(33%) of the
treatment
scores are
below the
extreme
baseline score
(30).
A participant
scored 21 on
their last BL
CUXOS and 19
on their last
treatment
CUXOS.
Change of
only -2
A participant
scored 33 in
their last week
in a baseline
phase and 31
in their last
week in the
treatment
phase - No
Change
moderate level

16

A participant
scored 33 in
their last week
in a baseline
phase and 25 in
their last week
in the treatment
phase. -Change
from Moderate
to Mild

Heart Rate
Variability
(HRV)

This metric provides for a comparison of HRV
between baseline and treatment conditions.
HRV consists of the variation among the
intervals between heartbeats and is measured
in milliseconds (ms). More variability between
beats is considered better as it indicated more
flexibility in responding to stimuli.
- Any increase in HRV is counted a positive
criterion toward an overall rating of effective.

A participant
scored 95 on
their Pre HRV
measurement
and 105 on their
Post
measurement.
+10 difference

A participant
scored 95 on
their pre HRV
measurement
and 92 on their
post
measurement.
-3 difference

*Effective-Four or more criteria met, Minimally Effective-Two or three criteria met, Not Effective-1 or less
criterion met. *Note: Lower CUXOS scores are desired.

Categories of Effective, Minimally Effective and Not Effective were created based
on the number of effectiveness criteria participants met, across the five metrics. The
benchmarks used for each criterion are listed in Table 1 and determined the manner in
which that criterion was counted toward the overall effectiveness rating. For a rating of
Effective, at minimum four out of five of the criteria were required to be met. A rating of
Minimally Effective required two or three of the criteria to be met. Lastly, for a rating of
Not Effective, one or fewer of the criteria were met.
In evaluating criteria, it was important to consider trends in the outcome data,
such as a gradual decline in symptoms from baseline to the conclusion of the
intervention, as this may be indicative of the manner in which symptoms of anxiety
respond to an intervention and potentially indicate that the intervention is having an
effect (Alberto & Troutman, 1990; Barlow & Hersen, 1973; Hixon et al., 2008). Using a
trendline (i.e. line of best fit, slope) for visual inspection serves this purpose. The
trendline depicted in all figures presented was calculated using Microsoft Excel’s linear
regression function. However, for ease of interpretation, a simple slope was calculated
that yielded the rate of CUXOS rating change per week. The simple slope was calculated
using the formula (y1-y2 / x1-x2) and entering CUXOS scores and corresponding
treatment week. Only the treatment phase slope was calculated, as in some instances
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there were not enough data points obtained in baseline phase to establish stability. A
negative slope indicates a reduction in CUXOS scores across the intervention phase (i.e.,
the desired direction).
Further evaluation was accomplished through visual inspection of the CUXOS
data to determine the intervention’s effects. Determining the percentage of overlapping
CUXOS data points between the range of baseline scores and all of the intervention
scores also helped determine whether the intervention had an effect. This method is
commonly referred to as the percentage of non-overlapping data points (PND). PND is a
simple measure of effect size for small subject design research (Riley-Tillman & Burns,
2009) that calculates the percentage of intervention data points that do not overlap with
the defined extreme baseline phase data point (Campbell, 2004). According to Scruggs
and Mastropieri (1998), a PND less than 50% is considered to warrant a conclusion of
“no observed effect”. The present study required 50% or more of non-overlapping data
points in order to be counted toward the overall effectiveness rating.
In addition to visual inspection, examining the quantitative change in CUXOS
scores between the last baseline score and last treatment score is useful for understanding
the magnitude of change throughout the intervention. A minimum change of minus 5
points was required to meet the criteria in order to count toward the overall effectiveness
rating.
Furthermore, evaluating categorical severity level changes measured on the
CUXOS assisted in determining whether the intervention showed practical utility. For
example, if a participant who scored in the moderate range of anxiety symptoms on the
CUXOS in the final baseline phase, and by the conclusion of the study showed a
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reduction of symptoms that could now be classified in the mild category on the CUXOS,
this result would indicate a practically significant change and count toward overall
effectiveness.
The final evaluation metric, HRV, was assessed using a heart rate monitor and is
based on the difference between the pre-intervention- and post-intervention
measurements. An increase in HRV over time is desirable indicating more flexibility in
responding to environmental stimuli and potentially signifying reduced stress. HRV is
measured in milliseconds (ms) and an increase in HRV between the start and end of the
treatment phase was considered another positive criterion toward the evaluation of
effectiveness.
Finally, although not included in the evaluative criteria for formal designation of a
category (e.g., effective, ineffective, minimally effective), an analysis of participants’
subjective experiences of the intervention was summarized and evaluated. (See
Appendix G for a complete compilation of participants’ responses.) Participants were
assigned pseudonyms to protect their identity, however common gender names are used
and are consistent with their actual gender.
Individual Participant Data
Participant #1 - James.
Treatment results for James. Outcome data for James’ CUXOS scores are
provided in the graph in Figure 1.
Figure 1.
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Overall, James’ data met one out of the five evaluation effectiveness criteria, for a
resultant overall effectiveness rating of Not Effective. James’ intervention results can be
described as follows. To begin, the average weekly change of the CUXOS scores was
+.20 during the treatment phase. A percentage of non-overlapping data (PND) evaluation
revealed that 0 % of CUXOS scores in the treatment phase fell below the lowest CUXOS
baseline score, thus indicating no change due to treatment was detectable. These two
indicators suggest insignificant effectiveness of the treatment. Related findings were
discovered in comparing the change in score from the last CUXOS baseline score to the
last CUXOS treatment score, which showed an increase of 15. Similarly, there was no
change in categorical severity level on the CUXOS and his scores remained in the
moderate anxiety range across both phases. Finally, on the measure of heart rate
variability (HRV), the difference between the baseline measurement and post-treatment
measurement was -8.9 ms (-10% change), indicating an unfavorable decline in HRV that
parallels James’s increase in CUXOS Scores.
Fidelity of treatment self-reporting. Table 2 contains a summary of James’ selfreported treatment usage information.
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Table 2.
James: Fidelity- Usage data
Responses collected out possible
reporting periods during intervention
(2x daily)
Proportion of daytime device was worn
Alerts with Anxiety "Device Anxiety
Accuracy detection"
Usage of SMHRB for Alerts with
Anxiety
Breathing w/o Device
Determination:

43%
100%
38%
94%
0
High
Usage/ Low
Reporting:

James completed 43% of the daily response requests, and of these responses he
reported wearing the heart rate device 100% of the time. Out of the total number of alerts
reported, 38% corresponded with subjective feelings of anxiety. Of the 38% of alerts that
corresponded with self-identified anxiety, James responded to those 94% of the time
using the SMHRB intervention. Finally, James did not engage in the relaxation breathing
without the heart rate monitoring watch.
Summary of self-reported subjective experience of the treatment. James reported
the intervention was "very simple to use," aside from getting used to the watch functions
initially. Further, he expressed it was difficult to respond quickly to daily questions,
especially because these seemed to be asked at times that were inconvenient such as "in
the middle of class." He also commented on the red flashing light on the watch that is
intended to alert the participant of an elevated heart rate. James noted that the red light in
some ways “became a trigger of sorts,” alerting the participant to be aware of being
anxious when on a number of occasions, indeed, he was not anxious. He also expressed
that the intervention was “Definitely helpful overall” and stated that he felt “more
relaxed.” Finally, James reported he would use the breathing strategies in the future “for
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sure” and, while he would not wear the watch as much in the future, he would, however,
use it on a more limited basis to assist with anticipated stressful experiences.
The information presented here suggests the treatment was not effective for James
even though he appeared to use the treatment with fidelity. Nonetheless, James reported
the intervention was easy to use and he further indicated his intent to utilize the strategies
in the future.
Participant #2- Abby.
Treatment results for Abby. Outcome data for Abby’s’ CUXOS scores are
provided in the graph in Figure 2.
Figure 2.

Overall, Abby’s’ data met five out of the five evaluation criteria for effectiveness,
for a resultant overall treatment rating of Effective. Abby’s intervention results can be
described as follows. To begin, the average weekly change of the CUXOS scores was 2.4 during the treatment phase. A percentage of non-overlapping data (PND) evaluation
revealed that 100% of CUXOS scores in the treatment phase fell below the lowest
CUXOS baseline score, thus indicating a reliable change due to treatment was detectable.
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These two indicators suggest significant effectiveness of the treatment. Related findings
were identified in comparing the change in score from the last CUXOS baseline score to
the last CUXOS treatment score which showed a decrease of 27. Similarly, there was a
substantial change in categorical severity level on the CUXOS and her scores moved
three levels from the Moderate Anxiety category to the Non-anxious category. Finally, on
the measure of heart rate variability (HRV), the difference between the baseline
measurement and post-treatment measurement was +11.5 ms (+11% change), indicating
a favorable increase in HRV that parallels Abby’s decrease in CUXOS Scores.
Fidelity of treatment self-reporting. Table 3 contains a summary of Abby’s selfreported treatment usage information.
Table 3.
Abby: Fidelity- Usage data
Responses collected out possible
78%
reporting periods during
intervention (2x daily)
Proportion of daytime device was
84%
worn
Alerts with Anxiety "Device
35%
Anxiety Accuracy Detection"
Usage of SMHRB for alerts with
100%
Anxiety
Breathing w/o device
15
Determination:
High
Usage/ High
Reporting:

Abby completed 78% of the daily response requests, and of these responses she
reported wearing the heart rate device 84% of the time. Out of the total number of alerts
reported, 35% corresponded with subjective feelings of anxiety. Of the 35% of alerts that
corresponded with self-identified anxiety, Abby responded to those 100% of the time
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using the SMHRB intervention. Finally, Abby reported engaging in relaxation breathing
without the heart rate monitoring watch 15 times.
Summary of self-reported subjective experience of the treatment. Abby reported
feeling as though the intervention was “easy to use,” once she was able to turn the wrist
worn device on and off and gained practice tracking heartbeat. Abby expressed that the
only difficulty was at first when there was some complication with charging the device.
Overall, Abby said there was a large difference between her level of anxiousness at the
beginning and end of the study and that she went from “extremely anxious, worrying
about little things ….to…barely have[ing] anxiety and much more calm and relaxed”.
Additionally, Abby said she would continue to use the intervention, but not every day as
she did in the study. Lastly, Abby found the tracking of elevated HR alerts to be difficult
to accomplish completely accurately.
The information presented here suggests the treatment was effective for Abby, as
all measures showed improvement and her outcomes produce a change of three
categorical levels on the CUXOS. She submitted her usage results regularly and reported
high levels of usage as well. Abby also reported the intervention was easy to use and that
she would keep using it.
Participant #3- Myra.
Treatment results for Myra. Outcome data for Myra’s’ CUXOS scores are
provided in the graph in Figure 3.
Figure 3.
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Overall, Myra’s data met five out of the five evaluation effectiveness criteria, for
a resultant overall effectiveness rating of Effective. Myra’s intervention results can be
summarized as follows. First, the average weekly change of the CUXOS scores was -.1.5
during the treatment phase. A percentage of non-overlapping data (PND) evaluation
revealed that 100% of CUXOS scores in the treatment phase fell below the lowest
CUXOS baseline score, thus indicating a reliable change due to treatment was detectable.
These two indicators suggest significant effectiveness of the treatment. Related findings
were discovered in comparing the change in score from the last CUXOS baseline score to
the last CUXOS treatment score which showed a decrease of 20 points. Similarly, there
was a substantial change in categorical severity level on the CUXOS and her scores
resulted in a change of two levels from the Moderate Anxiety range to the Minimal
Anxiety range. Finally, on the measure of heart rate variability (HRV), the difference
between the baseline measurement and post-treatment measurement was +25 ms (75%
change), indicating a favorable increase in HRV that parallels Myra’s decrease in
CUXOS Scores.
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Fidelity of treatment self-reporting. Table 4 contains a summary of Myra’s selfreported treatment usage information.
Table 4.
Participant 3-Myra: Fidelity- Usage data
Responses collected out possible
26%
reporting periods during intervention
(2x daily)
Proportion of daytime device was
100%
worn
Alerts with Anxiety "Device Anxiety
66%
Accuracy Detection"
Usage of SMHRB for Alerts with
90%
Anxiety
Breathing W/o Device
32
Determination:
High
Usage/ Low
Reporting:

Myra completed 26% of the daily response requests, and of these responses she
reported wearing the heart rate device 100% of the time. Out of the total number of alerts
reported, 66% corresponded with subjective feelings of anxiety. Of the 66% of alerts that
corresponded with self-identified anxiety, Myra responded to those 90% of the time using
the SMHRB intervention. Finally, Myra reported engaging in relaxation breathing
without the heart rate monitoring watch 32 times.
Summary of self-reported subjective experience of the treatment. Myra reported
that the intervention was “very easy to use,” and it became part of her “daily routine.”
She also liked the text reminders and said having the app on her phone was helpful. She
said other than occasionally forgetting to report her daily usage, she had no other
difficulties using the intervention. Myra also found the intervention helpful in becoming
“more mindful” about her anxiety, describing it as an alternative strategy to “taking a nap
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or staying in bed.” Lastly, she reported believing it is “important to keep going with this”
and that she will continue to use the intervention.
The information presented here suggests the treatment was effective for Myra, as
her results were favorable on all criterion and she improved two categorical levels on the
CUXOS that also corresponded to a HRV change of 75%. Although she did not submit
her usage results regularly, at the end of the intervention trial she did verbally report
extremely high levels of usage. Myra also had a substantially higher concordance
between HR alerts and subjective feelings of anxiety (67%) than the other participants.
Myra also reported the device was easy to use and appreciated the application and text
reminders and said she will use the intervention in the future.
Participant #4 - Amin.
Treatment results for Amin. Outcome data for Amin’s CUXOS scores are
provided in the graph in Figure 4.
Figure 4.

Overall, Amin’s treatment results data met three out of the five evaluation
effectiveness criteria, for a resultant overall effectiveness rating of Minimally Effective.
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Amin’s intervention results can be described as follows. To begin, the average weekly
change of the CUXOS scores was -.2 during the treatment phase. A percentage of nonoverlapping data (PND) evaluation revealed that 50% of CUXOS scores in the treatment
phase fell below the lowest CUXOS baseline score, thus indicating there may have been
some change due to treatment. These two indicators suggest potential significant
effectiveness of the treatment. Related findings were discovered in comparing the change
in score from the last CUXOS baseline score to the last CUXOS treatment score, which
showed a decrease of three on the rating scale; this was not substantial enough to count
toward an Effective rating. However, the change in CUXOS scores was not substantial
enough to produce a change in categorical severity level on the CUXOS. Thus, Amin’s
scores remained in the Moderate anxiety range across both phases. Finally, on the
measure of heart rate variability (HRV), the difference between the baseline measurement
and post-treatment measurement was 211ms (400% change), indicating an exceptionally
favorable increase in HRV. Although Amin did have some reduction in his CUXOS
scores, a corresponding change in HRV of such a large magnitude is unexpected and may
be an anomaly that is more related to change in fitness level than stress, or may have
resulted from equipment or measurement error.
Fidelity of treatment self-reporting. Table 5 contains a summary of Amin’s selfreported treatment usage information.
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Table 5.
Participant 4 - Amin: Fidelity- Usage data
Responses collected out possible
87%
reporting periods during intervention
(2x daily)
Proportion of daytime device was
96%
worn
Alerts with Anxiety "Device Anxiety
31%
Accuracy Detection"
Usage of SMHRB for Alerts with
60%
Anxiety
Breathing W/o Device
5
Determination:
Moderate
Usage/ High
Reporting:

Amin completed 87% of the daily response requests, and of these responses he
reported wearing the heart rate device 96% of the time. Out of the total number of alerts
reported, 31% corresponded with subjective feelings of anxiety. Of the 31% of alerts that
corresponded with self-identified anxiety, Amin responded to those 60% of the time
using the SMHRB intervention. Finally, Amin engaged in relaxation breathing without
the heart rate monitoring watch five times.
Summary of self-reported subjective experience of the treatment. Amin reported
that the intervention was “overall easy to use” and described the device and breathing
techniques as easy to learn and noted that they “did not interrupt” his daily routines. He
did feel that wearing the device at all times was difficult and noted that he would use the
breathing exercises in the future without the watch now that he has learned to monitor his
heart rate. Lastly, Amin noted that the blinking light was not a good indicator and may
have added to his anxiety if at the time, indeed, he was not already anxious.
The information presented here suggests the treatment was Minimally Effective
for Amin even though he had high reporting and appeared to use the treatment with
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fidelity. Finally, Amin reported the intervention was easy to use and he further indicated
his intent to utilize the strategies in the future.
Participant #5- Ginger.
Treatment results for Ginger. Outcome data for Ginger’s CUXOS scores are
provided in the graph in Figure 5.
Figure 5.

Overall, Ginger’s data met five out of the five evaluation effectiveness criteria, for
a resultant overall effectiveness rating of Effective. Ginger’s intervention results can be
described as follows. The average weekly change of the CUXOS scores was -.66 during
the treatment phase. A percentage of non-overlapping data (PND) evaluation revealed
that 100% of CUXOS scores in the treatment phase fell below the lowest CUXOS
baseline score, thus indicating a reliable change due to treatment was detected. These two
indicators suggest significant effectiveness of the treatment. Related findings were
discovered in comparing the change in score from the last CUXOS baseline score to the
last CUXOS treatment score which showed a decrease of 10. Thus, there was a
significant change in categorical severity level on the CUXOS, from Minimal to a Non-
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Anxious classification. Finally, on the measure of HRV, the difference between the
baseline measurement and post-treatment measurement was +2.7 ms (2%), indicating a
slight but favorable increase in HRV that parallels Ginger’s decrease in CUXOS Scores.
Fidelity of treatment self-reporting. Table 6 contains a summary of Ginger’s selfreported treatment usage information.
Table 6.
Participant 5 - Ginger: Fidelity- Usage data
Responses collected out possible
58%
reporting periods during
intervention (2x daily)
Proportion of daytime device was
95%
worn
Alerts with Anxiety "Device
28%
Anxiety Accuracy Detection"
Usage of SMHRB for Alerts with
94%
Anxiety
Breathing W/o Device
2
Determination:
High
Usage/ Modera
te Reporting:

Ginger completed 58% of the daily response requests, and of these responses she
reported wearing the heart rate device 95% of the time. Out of the total number of alerts
reported, 28% corresponded with subjective feelings of anxiety. Of the 28% of alerts that
corresponded with self-identified anxiety, Ginger responded to those 94% of the time
using the SMHRB intervention. Finally, Ginger reported engaging in relaxation breathing
without the heart rate monitoring watch two times.
Summary of self-reported subjective experience of the treatment. Ginger stated
that the intervention was easy to use, specifically in keeping track of elevated heart rate
alerts; however, she noted that the buttons on the device were unclear and challenging to
use. Ginger also noted that she experienced a decrease in anxiety and felt that deep
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breathing did bring her heart rate down to assist in this effect. She also noted that she will
continue to do deep breathing in the future with or without the device.
The information presented here suggests the treatment was Effective for Ginger,
as she had favorable results on all of the criteria and was able to reduce her categorical
severity ratings on the CUXOS from Minimal to Non-Anxious. This change, however,
was not accompanied by a substantial change in HRV. Here, Ginger experienced only a
2.7-point increase (2% change). Ginger had moderate reporting and high usage rates.
Finally, Ginger reported the device was easy to use and indicated she will continue to use
the intervention with or without the device in the future.
Participant #6 - Belinda.
Treatment results for Belinda. Outcome data for Belinda’s CUXOS scores are
provided in the graph in Figure 6.
Figure 6.

Overall, Belinda’s data met zero out of the five evaluation effectiveness criteria,
for a resultant overall effectiveness rating of Not Effective. Belinda’s intervention results
can be described as follows. To begin, the average weekly change of the CUXOS scores
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was +3 during the treatment phase. A percentage of non-overlapping data (PND)
evaluation revealed that 16.6% of CUXOS scores in the treatment phase fell below the
lowest CUXOS baseline score, thus indicating no change due to treatment was detected.
These two indicators suggest insignificant effectiveness of the treatment. Related findings
were discovered in comparing the change in score from the last CUXOS baseline score to
the last CUXOS treatment score, which showed an increase of 24 points. Similarly, there
was an unfavorable increase in categorical severity level on the CUXOS, for which her
scores changed from the Moderate Anxiety range in baseline to the Severe Anxiety range
at the end of the treatment phase. Finally, on the measure of heart rate variability (HRV),
the difference between the baseline measurement and post-treatment measurement was 8.9 ms (-21%), indicating an unfavorable decline in HRV that parallels her increase in
CUXOS Scores.
Fidelity of treatment self-reporting. Table 7 contains a summary of Belinda’s
self-reported treatment usage information.
Table 7.
Participant 6-Belinda: Fidelity- Usage data
Responses collected out possible
10%
reporting periods during
intervention (2x daily)
Proportion of daytime device was
75%
worn
Alerts with Anxiety "Device
31%
Anxiety Accuracy Detection"
Usage of SMHRB for Alerts with
80%
Anxiety
Breathing W/o Device
12
Determination:
High
Usage/ Low
Reporting:
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Belinda completed 10% of the daily response requests, and of these responses she
reported wearing the heart rate device 75% of the time. Out of the total number of alerts
reported, 31% corresponded with subjective feelings of anxiety. Of the 31% of alerts that
corresponded with self-identified anxiety, Belinda responded to those 80% of the time
using the SMHRB intervention. Finally, Belinda engaged in the relaxation breathing
without the heart rate monitoring watch 12 times.
Summary of self-reported subjective experience of the treatment. Belinda
reported that the wrist worn device could be confusing at times and that she had trouble
syncing with the app. However, she described the breathing exercises as helpful and said
the reminders helped her become more aware of her anxiety and how to manage it.
Belinda stated it was “most concerning” that the device would sometimes flash red when
she was not experiencing anxiety and remain red until her breathing exercises were
completed.
The information presented here suggests the treatment was Not Effective for
Belinda. Her unfavorable rise in CUXOS severity rating also corresponded to her rise in
HRV. Although she reported using the intervention with high fidelity, her reporting was
markedly low. While the intervention did not prove effective for Belinda, nonetheless she
reported the intervention assisted her in becoming more aware of her anxiety.
Participant #7- Sondra.
Treatment results for Sondra. Outcome data for Sondra’s CUXOS scores are
provided in the graph in Figure 7.
Figure 7.
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Overall, Sondra’s data met five out of the five evaluation effectiveness criteria,
for an overall effectiveness rating of Effective. Sondra’s intervention results can be
described as follows. To begin, the average weekly change of the CUXOS scores was 1.5 during the treatment phase. A percentage of non-overlapping data (PND) evaluation
revealed that 85% of CUXOS scores in the treatment phase fell below the lowest CUXOS
baseline score, thus indicating a reliable change due to treatment was detectable. These
two indicators suggest significant effectiveness of the treatment. Related findings were
discovered in comparing the change in score from the last CUXOS baseline score to the
last CUXOS treatment score, which showed a decrease of 15. Similarly, there was a
significant change in categorical severity level on the CUXOS and her scores moved one
level from the Moderate Anxiety category to the Mild Anxiety category. Finally, on the
measure of heart rate variability (HRV), the difference between the baseline measurement
and post-treatment measurement was +71 ms (137% Change), indicating a favorable
increase in HRV that parallels Sondra’s decrease in CUXOS Scores.
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Fidelity of treatment self-reporting. Table 8 contains a summary of Sondra’s selfreported treatment usage information.
Table 8.
Participant 7- Sondra: Fidelity- Usage data
Responses collected out possible
41%
reporting periods during intervention
(2x daily)
Proportion of daytime device was
80%
worn
Alerts with Anxiety "Device Anxiety
30%
Accuracy Detection"
Usage of SMHRB for Alerts with
71%
Anxiety
Breathing W/o Device
0
Determination:
High
Usage/ Low
Reporting:

Sondra completed 41% of the daily response requests, and of those responses she
reported wearing the heart rate device 80% of the time. Out of the total number of alerts
reported, 30% corresponded with subjective feelings of anxiety. Of the 30% of alerts that
corresponded with self-identified anxiety, Sondra responded to those 71% of the time
using the SMHRB intervention. Finally, Sondra did not report engaging in relaxation
breathing without the heart rate monitoring watch.
Summary of self-reported subjective experience of the treatment. Sondra
described the intervention as easy to use, with the exception of responding to daily
surveys, which she often forgot to do. She felt the intervention was helpful in reminding
her to take deep breaths when she saw a spike in heart rate, and also described it as
helpful in relaxing during stressful times. Sondra also said she would use the breathing
technique in the future if she feels anxiety coming on.
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The information presented here suggests the treatment was effective for Sondra,
as she met all criteria and moved a categorical level on the CUXOS which corresponded
to her favorable change in HRV score. Although her reporting was considered low, she
reported high levels of usage. Sondra also reported the intervention was easy to use and
she further indicated her intent to utilize the strategies in the future.
Summary of Results for Treatment Responders
Based on the results across the seven individual participants, overall the
intervention was considered Effective for 4/7, or 57%, of participants; Minimally
Effective for 1/7, or 14%, of participants; and Not Effective for 2/7, or 29%, of
participants. Across the five participants in the Effective and Minimally Effective
categories who were considered “responders” to the intervention, a comparison of the last
baseline CUXOS scores and the last treatment CUXOS scores showed an average
decrease of -15 points. Furthermore, 4/7 participants’ CUXOS ratings decreased a
categorical severity level between the last baseline phase and the last treatment phase.
These findings indicate the intervention had a positive effect for these participants, and
the magnitude of the decrease in symptoms is roughly equal to one and a half levels of
severity on the CUXOS. The average slope of the trendline in the treatment phase for
participants who responded well to the intervention is -1.25, signifying a desired weekly
incremental change over the course of the intervention. Furthermore, for the group of
responders, the average (PND) percentage of treatment points that fell below the lowest
baseline point was 87%. This indicates that participants who responded well had
subjective levels of stress which were lower in the intervention phase than the baseline
phase a majority of the time, and signifies a trend toward symptom reduction. Lastly, the
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average change in HRV for responding participants from the baseline phase (72ms) to the
end of the treatment phase (136ms) showed a favorable increase of 64ms for an average
HRV percent change of 88%. Participant four showed a HRV change that seemed to be
questionable, as it was an extreme outlier. Adjusting for this outlier would still yield a
favorable increase of 35% HRV for responders. With or without adjusting for the outlier
the increase is favorable and corresponds with the desired decrease in CUXOS scores,
indicating the two metrics are negatively correlated as anticipated.
Table 9.
Summary of Treatment Responder Data Results
Average. Difference Pre-Post CUXOS

-15

Average Slope (weekly reduction in

-1.25

CUXOS ratings)
Average (PND) Per Participant

87%

Average HRV Score Change (SDNN)

64ms (88%)

Average HRV Change Excluding Outlier

21ms (35%)

Overall Category Ratings
Effective 4/7 51%
Minimally Effective 1/7 14%
Not Effective 2/7 29%

Group Summary of All Participants’ Fidelity and Reported Usage
Participants’ overall reporting and usage data was delineated into two categories,
Reporting and Usage, for organizational and evaluative purposes. The categories were
also classified by percentage of usage. For example, for both self-reports and collected
responses, percentages of reporting and usage were defined for each participant into high,
moderate, and low classifications (i.e., above 70% = High, 50-70% = Moderate, Below
50% =Low).
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The category of reporting included the percentage of received responses to
investigator text messages out of the total responses that were possible. All participants
reported wearing the device at a high rate (more than 75% of the day); therefore, for the
usage category, classifications were determined by the percentage of instances in which
participants responded to HR alerts with subjective symptoms of anxiety.
The participants were asked to report their usage via text message. On average the
group of participants responded to a total of 49% (Low reporting) of their text messages.
This figure is lower than anticipated and falls just below this studies classification of
Moderate responding. The average proportion of time participants reported wearing their
device during the day was 90%. This figure was based on the responses received from
participants; there was no adjustment made for data not reported in daily texts. On
average 37% percent of alerts for each participant corresponded to subjective feelings of
anxiety. This number is an indication of the concordance of the devices with subjective
feelings of anxiety. This number is lower than anticipated and signifies that the HR alerts
did not match participants’ subjective feelings of anxiety a majority of the time. Out of
the alerts that were reported with anxiety, participants reported using the intervention
83% (High usage) of the time on average. This finding indicates that participants used the
intervention a majority of the times when an alert occurred and the participant was
experiencing subjective symptoms of anxiety. The group reported using relaxation
breathing without the device an average of 9.4 times through the entire treatment phase.
This number is comparatively low and likely did not influence symptom outcomes in any
direction.
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Table 10.
Summary of Participant Reported Usage
Range
Average
Category
(%)
(%)
Responses collected out
10 - 78
49
possible reporting
periods during
intervention (2x daily)
Proportion of daytime
80 – 100
90
device was worn
Participant Intervention
60 - 93
83
Usage for Alerts w/
Anxiety
*Proportion of Heart
28- 65
37
Rate Alerts w/ Anxiety
*This is a measure of device accuracy not fidelity

Low

High
High

Low

Summary of all participants’ responses to open ended questions. An informal
thematic and per-question analysis for participant responses was used to support and
establish conclusions and insights about the intervention. All seven participants said that
the intervention was easy to use, was helpful, and that they would continue to use a
version of it in the future (e.g., breathing with a device or without). Two of the seven
participants stipulated that they would only use the breathing aspect of the intervention or
use it with a different device. These reports are consistent with the study goals to link
emotional self-awareness and physiological awareness so participants may intervene with
symptoms of anxiety in the future without utilizing a device. Moreover, two participants
noted that the text messages were beneficial (“text reminders were great”, “helpful”).
Three participants also specifically noted that they believe the intervention helped lower
their anxiety overall (participants were not asked explicitly about levels). One participant
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described it as a better alternative to “taking a nap or just staying in bed,” and indicated
“it [the intervention] helped to try and get through it.” Others noted the “breathing was
easy” and they could “do it on the go” and the “quantitative data” (HR) was helpful in
relaxing.
The majority of the participant feedback for the intervention was positive.
However, there were also applicable constructive criticisms as well as some concerning
themes in the data. First, as previously mentioned, two participants found the text
messages helpful; however, three others indicated that they consistently forgot to respond
to them. Additionally, four participants suggested they had some trouble acclimating to
the watch functions initially and some difficulty using it effectively at first. Lastly, and of
particular concern regarding the intervention use and effects, three participants suggested
that when the red light on the watch was flashing, and they did not feel anxious, it was
bothersome enough that it seemed to prompt subjective feelings of anxiety. It is notable
that the three participants who found the flashing red light intrusive also achieved the
most unfavorable results on the CUXOS.
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Chapter 4:
DISCUSSION
Summary of Findings
This research examined two primary questions and hypotheses. The first was to
examine to what extent were college students with “mild to moderate” levels of anxiety
able to utilize self-monitoring heart rate biofeedback (SMHRB) consistently (e.g.,
respond to at least 70% of maximum HR alerts utilizing relaxation breathing). The
second, and related, question examined to what extent did participants who consistently
implemented relaxation breathing in response to a Maximum HR alert significantly
reduce symptoms of anxiety from baseline levels on a global anxiety scale?
Self- reports for each individual indicate that all participants wore their devices
more than 70% of time during the day. Additionally, six participants utilized the
intervention more than 70% of the time and one participant utilized it 60% of the times
when a HR alert corresponded with subjective feelings of anxiety. These self-reported
results indicate that participants used the intervention in a manner consistent with the
hypothesis. Furthermore, these results also indicated that future research utilizing
interventions with wearable technology with college students in real world settings is
viable.
Moreover, four participants showed improved measurements in HRV and
CUXOS ratings. Additionally, all of their results also revealed a progressive trend toward
improvement in anxiety symptoms during the intervention phase. Taken together these
results indicate the intervention had a significantly positive effect for a majority of the
participants.
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All participants wore their devices a majority of the time, and the group reported
wearing their wrist monitor an average of 90% of the daytime as indicated by their twice
daily responses. Further, they utilized self-monitoring to intervene with subjective
feelings of anxiety consistently (83% percent of instances as indicated by self-report).
Although participants generally reported high usage, they also noted that many
false positives occurred. That is, participants reported that 64% of HR alerts did not
correspond to subjective feelings of anxiety across participants. This means if a
participant received ten alerts in one day, approximately three of them would correspond
to subjective feelings of anxiety. These reported estimates, however, should be
interpreted with caution, first, because they are based on self-reports and, second, because
of the lower-than-anticipated rates of reporting in response to text message prompts
(49%).
Furthermore, the majority of participants who had a decrease in CUXOS ratings
also exhibited an average improvement in HRV scores from baseline. These results
indicate that the intervention did have a significantly positive effect for most participants
and also suggest that the measure of HRV is correlated with symptoms of anxiety as
measured by the CUXOS.
Interpretations of results in the context of missing and unverifiable data. One
of the challenges of an “in vivo” research study relative to a more controlled environment
type of study is adequately ensuring participant engagement in specified activities and
reporting of self-monitoring information. Although difficulties with ensuring participant
treatment fidelity is a limitation of this study, it is nonetheless pertinent to the
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investigation. Determining whether a participant can consistently follow the procedures
is another measure indicating whether this type of intervention is viable.
Although the importance of determining viability is not in question, the
determination of how to consider intervention protocol adherence is difficult to resolve.
A critical consideration in this study is the limitations of the usage data. Participants on
average responded to 49% of all text messages (range of 9.5%-77.6%). This result leaves
a great deal of uncertainty as to how to interpret missing data (non-responses to texts for
daily usage). One possible interpretation may generate the question: does the lack of
reporting negate participant estimates of usage and equate to a lack of intervention usage?
Another question that could be generated is, does this lack of usage correlate with lower
CUXOS scores? This conclusion may be plausible, as both of the participants with
Ineffective outcomes had a low percentage of reported data (43% and 9.5%). However,
two other participants who had effective outcomes also had low reporting (26% and
41%), making that conclusion questionable especially with such a small number of
participants.
The previous question about equating the lack of participant responses to lack of
intervention usage requires a consideration of the aims of the study. The intention of this
exploratory study using a small n design is to use participant self-report and outcomes to
make recommendations for similar research in the future. Thus, interpreting results using
the information provided by participants, with caution, seems to be the most viable
option. Additionally, in the open-ended questionnaire, some participants expressed
concern with their ability to keep accurate records of alerts. A potential difficulty in
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overall reporting accuracy, combined with higher than anticipated rates of missing data,
call for even more caution in the interpretation of the results of this study.
It is clear that the limited quantity and verifiability of usage data warrant caution
in the interpretation of results. However, the finding that the collection of usage data was
limited and difficult to verify is also valuable, as part of the research question was to
determine the ability of college students to be able to execute such an intervention.
Additionally, this being one of the earliest studies to examine self-monitoring using heart
rate biofeedback in vivo rather than in a laboratory setting, there was an expectation that
there would be some loss of control and verifiability over the independent variable.
Importance of using multiple outcome measures. The analysis of this research
differs somewhat from typical anxiety treatment research for a variety of reasons. First,
the present work used an innovative approach to treatment using a secondary prevention
intervention methodology that is relatively novel (SMHRB). Second, using multiple
techniques to examine the intervention’s utility is necessary to determine effectiveness. In
an effort to avoid type one error and concluding the intervention is effective when it is
not, or a type two error concluding the intervention is not effective when it actually is,
multiple outcome assessment methods were employed to help increase confidence that
the intervention was evaluated fairly.
Lastly, best practices in the interpretation of research using small n design
encourage the use of multiple evaluation strategies for examining the data. These include,
for example, analyzing a line of best fit and slope of that line. Other recommended
techniques include the use of total values for participants or mean values for groups as
well as percentage of non-overlapping data, PND (Scruggs and Mastropieri, 1998). The
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present research also utilized a less-studied experimental measure of HRV as an added
measure of stress. Using both the HRV and the CUXOS measures was intended to
provide for a more comprehensive assessment of treatment effectiveness.
Significance of the results in a secondary prevention framework. The
SMHRB intervention was intended, as intervention at the secondary level of prevention,
and therefore was designed to prevent and manage milder symptoms of anxiety. Within
this context, it seems fitting that the three participants experiencing the least favorable
results, Minimally Effective and Ineffective, experienced on average baseline scores in
the Moderate range of severity on the CUXOS. Additionally, one of the participants had
average baseline scores on the higher end of the moderate range (37), and one participant
had an average baseline score that ended up in the severe range (41.5) before the baseline
period ended. This information may point to the limitations of the intervention's
effectiveness with participants experiencing more moderate to severe anxiety symptoms.
As previously mentioned, the SMHRB intervention research study yielded some
favorable outcomes for a majority of participants and an average decrease across those
responding participants of approximately 15 points on the CUXOS between the final
weeks of each phase. This is substantial in that 15 points is roughly equal to one and a
half of a severity levels on the CUXOS (e.g., Moderate (30) – Mild (20) = 10). A
decrease of 15 points represents a tangible change for someone with symptoms of
anxiety.
SMHRB anxiety outcomes compared to previous work. The results of the
present study are consistent with those of Vitasari et al. (2011) who found that university
students significantly improved their scores on an anxiety measure using HRV as a
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mechanism to support biofeedback training in a laboratory setting. Although Vitasari et
al. (2011) used heart rate biofeedback as an intervention tool to reduce stress, they used
HRV in a laboratory setting rather than HR in real world settings as did the present
SMHRB work. SMHRB research extends the work of Vitasari et al. (2011) through the
expansion of interventions using biofeedback measures in the context of activities of
daily life. Thus, the present work suggests that biofeedback measures may be viable for
use outside of the laboratory for anxiety treatment research.
Other studies also have found similar results to those of the present study, but
again in laboratory settings (Ratanasiripong et al., 2012; Reiner, 2008). For example,
Reiner (2008) found in his twenty-four-participant pilot study that a majority of
participants reported that using HR biofeedback reduced anxiety levels and increased
relaxation more than mindfulness, yoga, and breathing. Such research indicates the strong
potential of biofeedback to reduce stress in comparison to other established interventions.
However, Reiner (2008) did not use a formal anxiety scale to measure participants’
change, and similar to Vitasari et al. (2011) the research was also conducted primarily in
laboratory settings. Unlike Vitasari et al. (2011) the present study did not pair the
intervention against a control or an alternative intervention. Nonetheless, the present
work does add to the body of work supporting the use of biofeedback measures to reduce
symptoms of anxiety.
Implications for future use of rating scales using mobile technology. In
addition to the effectiveness of SMHRB and the implications for future practice there
were also some positive implications for the research methods employed in the study that
extend previous work. As an example, Turner et al. (2014) studied the effectiveness of
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combining HR biofeedback with didactic instruction for students enrolled in a university
stress management course. The results showed significant decreases in anxiety and a
large effect size on a pre-post Beck Anxiety Inventory (BAI) as compared to a control
group. The present SMHRB study found results that were less robust; however, the
results extended the work of Turner et al. (2014), with the utilization of HR in real world
settings and the successful employment of an established rating scale, the CUXOS. The
usage of the CUXOS by participants was impressive as all participants submitted 10 out
10 rating scales outside of the lab via text messages. This finding indicates the viability of
using weekly online ratings scales for future research to measure symptom change in a
reliable, consistent and convenient way in real world settings. Thus, a larger study may
be able to employ text-message-linked forms on a weekly basis to collect self-report
measurement data rather than the more common pre- and post-measurement
methodology.
Implications of the correlation between HRV and CUXOS. Another
noteworthy finding of the present work was that participants who showed a favorable
reduction in symptoms on the CUXOS also showed a favorable HRV increase of 35%
compared to baseline, on average. Likewise, participants who had less favorable results
showed an unfavorable HRV decline of 23% on average. This finding is important as it
provides additional validation of the self-reported CUXOS outcomes. This finding also
lends further support for continued use of HRV as a measure of stress in future work of
this type. Finally, the finding is consistent with other research findings, showing
significant correlations between HRV and symptoms of stress and anxiety in a variety of
populations (Kim et al., 2018).
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Analysis of treatment utilization data. Treatment utilization (i.e., usage) data
was also favorable; however, the limited amount of text message reports collected was
somewhat disappointing. Just under half of all twice daily text message questionnaire
responses were submitted by participants on average. This is not consistent with other
research utilizing daily self-reporting. Chung et al. (2018) collected daily self-reports of
depression symptoms in a study in South Korea and reported 100% daily compliance
from all 20 participants for two weeks. It also is not consistent with another depression
and anxiety research study, using self-reports of treatment-seeking adults for 10 days,
where only 3% of participants had reporting less than 80% (Naragon-Gainey, 2019). One
explanation for these differences may be that, relative to the present work, these studies
had substantially shorter required reporting periods and were conducted with different
populations. Additionally, Chung et al. (2018) recruited treatment-seeking adults and
paid participants approximately $1 per self-report submitted, which likely contributed to
the higher rates of responding. The more consistent participant reporting in the previous
studies warrant greater consideration of compensation and treatment length in future
work in order to improve reporting of and use of prescribed treatments.
Implications of treatment phase length. Treatment phase length is another
factor that potentially influenced the participants’ outcomes. A comparison of the length
of time participants spent in a treatment phase and their final CUXOS outcome ratings
suggested the three participants with the least favorable outcomes (Ineffective, Minimally
Effective) were all randomly assigned to be the only participants in phase three of the
intervention. Participants in phase three of the intervention had six weeks in the
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intervention phase, compared with the other participants who spent seven or eight weeks
in the intervention and whose results were Effective.
Relatedly, two of the three participants with the least favorable results, Amin
(Minimally Effective) and James (Ineffective), both began to show some minimal
improvement in scores on their final two weeks’ (weeks five and six) CUXOS ratings.
While Amin’s best rating on the CUXOS was his last week (week six), James had
relatively improved (low) scores on his last two ratings, causing a downward-sloping
trendline.
Further support for the potential effect of treatment length is illustrated by the
participants that had the best results. Abby and Myra were among those with the greatest
decline in symptom ratings from baseline on the CUXOS and had been randomly
assigned to phase one (eight weeks in treatment phase). Ginger and Sondra were
randomly assigned to phase two (seven weeks in intervention phase) and showed slightly
more modest results than Abby and Myra (phase one, eight weeks in intervention). All of
the participants with Effective ratings also showed a relatively stable decline in CUXOS
score, including their final measurement. Overall, those who participated in the
intervention phase for longer lengths of time experienced better outcomes than those who
participated for shorter lengths.
It is interesting to conjecture that a longer intervention period may have yielded
improved results for Amin and James. Finally, future research studies with in vivo
biofeedback interventions should consider using a longer eight week intervention period,
rather than a shorter, intervention timeframe.
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Limitations
Heart rate alert accuracy. One of the discouraging, yet important, outcomes of
this study was the reported lack of concordance between the heart rate alert (red flashing
light) and reported subjective feelings of anxiety. Results from participant-reported usage
estimates show just 37% of alerts corresponded with subjective feelings of anxiety; said
another way, 63% of alerts seemed to be inaccurate from the participants’ perspectives.
Although subjective appraisals of anxiety do not necessarily wholly verify accuracy, a
higher percentage of concordance would be more desirable. This perceived heart rate
alert inaccuracy could be due to several factors. First, participants may have had
difficulty keeping track of alerts, and, in fact, three participants stated that keeping track
of the alerts accurately was difficult for them. This is especially likely as the alert
indicator is an unobtrusive flashing light and unless a participant happens to be looking at
the indicator, they may not notice it. This could result in some HR alerts resulting in no
response from a participant . Second, participants’ baseline heart rate data may not have
been as accurate as necessary. For example, in obtaining the initial baseline heart rate, the
circumstances or the measurement procedure may have led to a baseline heart rate that
was too high or low and did not represent their true resting relaxed heart rate.
Additionally, there may have been discrepancies between participants’ subjective
emotional states and their anxious heart rate. For example, when some participants
experienced anxious symptoms, their heart rate may have been higher or lower than the
threshold of 5 bpm fluctuation, used to trigger the HR alert, thus leading to relatively
inaccurate HR alerts.
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The inaccuracy between the HR alert and participants’ subjective symptoms of
anxiety is especially concerning for future research, predominantly because of the
qualitative information disclosed in the open-ended question responses, in which three
participants expressed their frustration with the inaccuracy of the HR alert. Specifically,
the three participants implied that when the alert was active (red), and they felt they were
not experiencing symptoms of anxiety, they then experienced stress. Moreover, it is not
surprising that these three participants who experienced this discomfort were also the
participants whose results were least favorable. Prior to conducting future research in this
area with a similar device and method, it is imperative to improve the concordance of the
alert or improve training in how to deal with alerts that don’t correspond to subjective
feelings of anxiety. Although not conclusive, it seems plausible that the intervention was
not as successful for participants at least partially because of the mismatch between alerts
and subjective symptoms.
Missing data and challenges with verification of data. As previously
mentioned, a critical challenge in this study is the limitations of the usage data.
Participants on average responded to 49% of all text messages (range of 9.5%-77.6%).
This finding generates questions as to how to interpret missing data (i.e., non-responses
to texts for daily usage). Critical examination could lead one to interpret that it is likely
that if a participant is not reporting data than they are also likely not using the
intervention. The SMHRB interpretation of results did not make the assumption that
reporting and usage were equivalent. Rather, it was assumed that the participants’ own
estimates of their usage were the most accurate reflection of their usage data. Therefore,
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the inability to verify data, coupled with higher than anticipated rates of missing data, call
for an abundance of caution in the interpretation of the results of this study.
Implications for Future Research and Practice
Possible solutions to the accuracy of HR alert to predict subjective symptoms
of anxiety. Just prior to the start of this research study some heart rate devices and
applications (Apple watch) have shown that prolonged data collection over time (several
days) can yield a more accurate measure in relation to a user’s typical resting heart rate.
Therefore, wearing a watch continuously for several days and nights during a pretreatment phase would allow for a more complete assessment of when a user’s heart rate
would be considered in a resting state and when it would be considered in an anxious
state. Through collection and utilization of this more extensive cardiac data, researchers
may be able to obtain more precise baseline data and more accurately determine a
threshold HR alert for participants.
Furthermore, with the reduction in cost and increase in availability of a variety of
devices, researchers can more easily utilize existing third-party applications to collect HR
data. Whether researchers customize or use existing applications, users could report their
subjective emotional states as soon as a detected change in HR occurs. Over time the
application would match self-reports of emotional states to physiological states, building
a profile that would allow for a more accurate tailored alert and intervention system.
Possible solution to collection and verification of data in future research. The
present study does employ relatively recent technologies in its design (e.g., text message
delivery, Google Form survey collection, optical heart rate monitoring); however, it
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lacked the advanced technology that the most recent, more expensive devices employ to
allow for optimal integration in data collection.
In addition to the previously mentioned enhancements to improve heart rate and
anxiety detection, new devices and technology recently released will allow for a marked
improvement in the ability to verify and monitor the use of the independent variable
(usage data) instead of relying on self-reports. Newer, more expensive devices (e.g.,
Apple watch) permit the use of third-party applications which will allow for a common
platform for physiological data measured by a device to be collected automatically. An
application of this nature would allow consumer devices (e.g., Apple watch) to share
heart rate and other data with researchers on a common platform. A platform would allow
researchers to collect almost all of the data more seamlessly and accurately. For example,
with participant permission, the researcher would have access to more objective data,
such as: frequency of use; duration; and a record of heart rate throughout the day, which
would include the number of HR alerts, to name a few. In future research, choosing a
device that has the capability and compatibility to accommodate the previously discussed
functions will be essential in obtaining generalizable results. Additionally, a reduction in
the cost of these devices and the availability of these features will likely make them more
accessible for use in future research.
Conclusion
The results of the research study are mixed in terms of finding the experimental
treatment to be effective, with four of seven participants experiencing improved
symptoms of anxiety linked to the intervention. Although the intervention showed a
reduction in anxiety for the majority of participants, the limited responses of participants
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and difficulties with verification of intervention usage limits the ability to conclusively
attribute intervention usage to results. Nonetheless, participants reported they were able
to wear the heart rate monitoring device a majority of the time prescribed, and respond to
a majority of alerts that correlated with subjective feelings of anxiety. Results also
showed that participants were able to provide weekly data using an online self-report
measure (CUXOS) through text messages extremely consistently (100%) and using the
CUXOS as weekly collection method is viable for future research with anxiety.
Viewing the results within the scope of a secondary prevention and management
framework, it seems to fit that on average the most severely affected participants had the
least favorable outcomes. However, there are also results that point to intervention
shortcomings, such as alert accuracy as well as discrepant time in intervention phases
between participants, which may have led to lower anxiety symptom ratings. In future
research, potentially standardizing and increasing the length of intervention phases, along
with recruiting a larger sample size and utilizing multiple groups, will allow for isolation
of interventions component effects as well as identifying effects on specific sub-groups of
our population. For example, it will be important to investigate treatment effects as a
function of age, gender, and ethnicity, which could yield more nuanced and
generalizable results.
Moreover, before conducting future research on HR biofeedback utilizing an alert
function, a more reliable method of establishing participants’ baseline levels of heart rate
will be necessary. Although wearable device technology is still in its infancy, it has
reached a point that its substantial, reliable, and positive influences on human functioning
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are possible. Wearable technology has tremendous potential for the future treatment of
mental health concerns, and it continues to be an important area for future research.
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Appendix A
Review of Literature
What is Anxiety?
“Anxiety disorders include disorders that share features of excessive fear and
anxiety and related behavioral disturbances. Fear is the emotional response to real or
perceived imminent threat, whereas anxiety is the anticipation of future threat. Obviously,
these two states overlap, but they also differ, with fear more often associated with surges
of autonomic arousal necessary for fight or flight, thoughts of immediate danger, and
escape behaviors, and anxiety more often associated with muscle tension and vigilance in
preparation for future danger and cautious or avoidant behaviors… Sometimes the level
of fear or anxiety is reduced by pervasive avoidance behaviors” (DSM-5).
Variations by Age and Culture
Worry seems to become prominent in the elementary years, at approximately age
4, and varies in complexity. During the typical course of development, the quantity and
intensity of worry and fears decline with age (Schultz et al., 2005). A majority of children
who develop anxiety during childhood will remit in 3 or 4 years (Gullone, 2005). Sex
differences in development also exist. Evidence indicates that girls exhibit more intense
as well as a greater number of fear responses than boys (Gullone, 2000). However,
gender differences need to be interpreted with caution, as gender role differences may
skew presentation and reporting of fears, phobias, and anxiety (Ginsburg & Silverman,
2000). Children seem to have common fears at specific age ranges. For example, in the
pre-school years between 6-9 months, children fear strangers; 2-year-olds fear monstertype creatures; at four years of age, children are afraid of the dark; and typically, in the
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middle school and high school years, older children and adolescents exhibit social fear
and fear of failure (Gullone, 2000; Miller, Barrett, & Hampe, 1974).
Additionally, there is evidence that the most common fears in children are similar
across cultures. There may, however, be some cultural variations as to the specific
content feared in each category type (Portman, 2009). For example, in high school, stress
and worry related to acculturation and discrimination may be more prevalent in
populations who have recently immigrated. There is additional evidence of variation for
individuals from collectivist cultures. Collectivist cultures (i.e. those found in some Asian
countries) emphasize the needs and goals of the group as whole over the needs and
wishes of each individual (as is the focus in individualist cultures, i.e. the U.S.). Research
indicates that individuals from collectivist cultures report increased internalizing
disorders, and in some Asian cultures people are also more likely to present with somatic
symptoms of anxiety such as stomach pain (Valerla et al., 2004).
The developmental period of childhood is marked by varying fear and worry
which can be considered typical (McKay & Storch, 2011). Additionally, some degree of
apprehension, fear, and anxiety serve essential adaptive functions. Fear in response to an
actual life-threatening event can prepare our body for a vital "fear" response, initiating a
life-saving flight or fight response. Moreover, some apprehension or anxiety about an
upcoming event, an exam for example, can serve as motivation to prepare. Alternatively,
if the fear or anxiety creates significant enough discomfort as to interfere with
functioning, this could be considered atypical, and assessment and intervention may be
warranted (Fonesca, Yule, & Erol, 1994).
Why is Anxiety a Problem?
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Anxiety disorders can impair a child's ability to learn and self-regulate and may
severely affect their relationships (Beesdo, Knappe, & Pine, 2009). For a variety of
reasons, up to 80% of children with an anxiety disorder do not receive treatment (Taras et
al., 2004). The most prevalent of all psychological disorders (Beesdo, Knappe, & Pine,
2009), anxiety is characterized by chronic symptoms of persistent worry (Parker, 2015)
and can manifest with a variety of physical and emotional symptoms (Goldberg, 2014).
Evidence suggests that as many as 29% of the population will be affected by an anxiety
disorder and those with the condition are at a greater risk of developing other chronic
medical conditions. The relationship between poor test performance and anxiety is well
documented; however, less apparent is the reality that anxiety can have a significant
impact on the education and development of children. Anxiety interferes with the ability
to regulate thoughts, actions, and emotions, and disrupts short-term memory involved in
learning. There is also evidence to suggest that chronic stress during critical
developmental periods can change brain structures more permanently than acute stress,
thus impairing future learning, behavior, and health (Shonkoff et al., 2011).
Theories of Anxiety Etiology and Maintenance
Cognitive theories. One of the most influential theories relating to anxiety is
Beck's Cognitive Theory. The underlying premise of this theory is that pathological
anxiety is derived from a misperception of danger which results in distortions in the
perception of information and stimuli. Beck's approach describes negative automatic
thoughts and schemas about the world, self, and other (the cognitive triad) as the
maintenance of anxiety (Chambless & Ollendick, 2001).
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Contemporary models based on Beck’s work integrate the learning process of
behavioral models (associative and non-associative) with cognitive perspectives. The
behavioral view assumes that learning takes place through classical conditioning to
stimuli and through behavioral reinforcement (operant conditioning). The cognitive
approach assumes that anxiety is a result of an overestimation of danger, threat, and fear,
as well as an underestimation of self-efficacy to cope with potential threats (Portman,
2009). Cognitive Behavioral Therapy (CBT) is designed to improve coping skills to
leverage improvement in behavioral, emotional and cognitive processes in a reciprocal
manner to improve affect. Essentially, positive change in cognition fosters improvement
in behavior and emotions in a continually enhancing cycle (Mckay, 2011).
Biological theories. Cognitive and behavioral theorists acknowledge the
influence of biological factors on anxiety disorders. Individual temperament is one such
factor that may be largely inherited. Family studies indicate children whose parents have
an anxiety disorder are at a greater risk of developing an anxiety disorder themselves
(Merikangas, 2005). Although the prevalence of anxiety in families is high, twin studies
suggest the genetic heritability component of the disorder is only moderate (Eaves et al.,
2010). This may be due to strong environmental influences operating in families.
Biological influences also include neurotransmitters, autonomic nervous system
functioning, brain circuitry and more. Structural and functional imaging studies have
implicated the amygdala, often called the emotional brain, in anxiety disorders
(Labuschagne, Phan, Wood, et al., 2010). The ventromedial prefrontal cortex (involved in
explicit cognitions) also plays a role in anxiety disorders, as there is decreased activation
in fMRI studies when subjects with anxiety are exposed to fear stimuli (Greenberg et al.,
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2003). A simplified explanation is that the combination of increased activation of the
amygdala, coupled with decreased activation of the ventromedial prefrontal cortex, is
implicated in the neurobiological experience of anxiety (Pine, Guyer & Leivenluft, 2008).
Interventions such as positive self-talk have shown an increase in activity between these
areas, which is linked to a decrease in fear response. Hypothetically, increasing positive
self-talk may cause the increase in the connection between these two areas and serve to
down-regulate (influence from prefrontal cortex to limbic regions) the anxiety and the
fear response.
There is also substantial ongoing research investigating the role of
neurotransmitters in anxiety. The dysregulation of GABA-involved circuits has been
implicated in the etiology of anxiety (Nutt, 2001). Medications such as benzodiazepine
are designed to treat anxiety and calm or inhibit transmission of neurotransmitters that act
on GABA receptors. Additionally, glutaminergic neurotransmission, an excitatory
pathway, may also be involved in the biological mechanisms underlying stress response
and anxiety-related disorders. Moreover, although not well understood, it is widely
accepted that serotonin plays a crucial role in anxiety, as the anxiolytic effects of
selective serotonin reuptake inhibitors (SSRI’s) are considered the first line of treatment
for anxiety disorders (Portman, 2009).
Furthermore, the autonomic nervous system, divided into the sympathetic and
parasympathetic system, plays a significant role in the physiology of anxiety disorders.
Increased heart rate is commonly recognized as a symptom of anxiety and is produced by
the mechanisms of the sympathetic response that prepares the body for a flight or fight
response. Children with anxiety disorders are said to have a dominant sympathetic
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system. The parasympathetic system restores relaxation to the body, such as reduced
heart rate, restoration of digestive functioning, and reproductive functioning, among other
things (Thayer et al., 2012). In the last decade a greater emphasis has been placed on the
bidirectional potential of interventions to act on the autonomic system with the use of
biofeedback in anxiety disorders. For example, heart rate biofeedback may have the
potential to increase parasympathetic functioning, thus reducing heart rate and returning
calm to the individual.
Biological theory and Heart Rate Variability. An extension of the biological
theory is described through the use of heart rate variability. One prevalent theory
describes anxiety’s roots in childhood temperament and heart rate variability (HRV)
(Ratanasiripong et al., 2004). Multiple theoretical models attempt to explain the
relationship between physiology and psychological functioning. For example, the
neurovisceral model of anxiety describes a relationship between the cognitions involved
in regulating anxiety and the autonomic response. Additionally, the polyvagal theory
describes the relationship between deliberate actions by the individual that result in
changes in biological states, such as deep breathing and relaxation efforts (Quintanna et
al., 2012). When examining heart rate as a marker of reactivity, anxious and non-anxious
individuals initially respond similarly to environmental stressors with temporary
increases in beats per minute (BPM) of approximately 5-10 (Stewart, Buffett-Jerrott, &
Kokaram., 2001). Although BPM is a crucial marker of normal acute environmental
stress, the measure that distinguishes between those who struggle with chronic stress and
anxiety and those who do not is the rate at which HR is returned to its resting state after
experiencing a stressor. Those who experience a stressor and can more quickly recover
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their heart rate to a resting state exhibit higher heart rate variability (HRV). HRV is
negatively correlated with overall stress level. More precisely, HRV is the variation in the
time interval between heartbeats. Thus it is preferable to have higher HRV as it shows
more versatility in responding to environmental stimuli such as the ability to more
quickly reduce heart rate in response to a benign threat. It is measured by the variation in
the beat-to-beat interval (Ratanasiripong et al., 2004). Moreover, many studies have
found that the relationship between HR and anxiety is bi-directional, indicating that
interventions that promote more effective cardiac control can facilitate improved
emotional regulation and anxiety reduction (McKenna, Gallagher, Forbes, & Ibeziako,
2015; Ratanasiripong et al., 2004; Quintanna et al., 2012; Vitasari et al., 2011).
Impediments to Treatment
Although anxiety in adolescents is well-documented, anxious youths are
frequently under-identified. Unlike students with externalizing disorders, those with
internalizing disorders such as anxiety usually do not outwardly express behaviors. By
not posing an immediate disruption in the classroom, students with internalizing disorders
thus present a less-perceptible concern (Herzig-Anderson, Colognori, Fox, Stewart, &
Masia Warner, 2012). Correctly identifying adolescents with anxiety is only one obstacle
to treatment. Additional impediments include treatment costs, time commitment,
accessibility (Dennis & O’Toole, 2014), and issues with the acceptability of treatment for
students with anxiety, such as social stigma and over-use of unsupported treatments in
community settings (Herzig-Anderson et al., 2012).
The various impediments to quality community-based treatment influence
approximately 70% of students identified as needing services to obtain them through their
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educational institution. Schools may have fewer barriers for students to receive treatment,
such as the need for transportation and added family costs. Additionally, schools offer
unique opportunities to practice real exposures and directly engage with particular
stressors, such as tests and peer interactions (Herzig-Anderson et al., 2012).
Although schools may offer advantages for treatment, many are notably
overwhelmed with students who need mental health services. Moreover, many
institutions, especially those in K-12 settings, are lacking the necessary funding and
resources to treat students with mental health concerns such as anxiety (Taras et al.,
2004). While challenges will persist for many populations in need of mental health
treatment, new technologies and innovations are offering alternatives to traditional
treatment methods. Many of these options utilize wearable technology, biofeedback, and
smartphones. The ubiquity, availability, and cross-cultural acceptance of these
interventions allow them to traverse traditional boundaries to treatment such as cost,
accessibility and negative stigma (Dennis & O’Toole, 2014).
Self-monitoring
Most technologies that allow for improvement in symptoms of anxiety utilize
elements of self-monitoring (SM) as an essential feature. Self-monitoring is the act of
measuring one’s target behavior and comparing it to an external standard or goal that can
result in lasting improvements to that behavior (Kazdin 1989).
SM has been used as a stand-alone intervention and permits students to track their
mental states independently. Improvements in behavioral outcomes have been noted with
SM, without any additional intervention (Shapiro & Cole, 1999). SM has been used to
influence a variety of behaviors such as helping individuals: maintain appropriate social
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skills; mitigate work competition; and as self-regulate behaviors involved in anxiety. Use
of self-monitoring is primarily based on the behavioral principle that the act of measuring
one's target behavior and comparing it to a standard can result in enduring improvements
to that behavior. Self-monitoring can be described as having reactive effects, in that those
who utilize it often react to this monitoring information to change behaviors in the
desired direction (Kazdin 1989).
Through self-monitoring, individuals can learn to recognize emotional states and
to identify and differentiate various emotions in different contexts (Kauer et al., 2012).
Learning to recognize emotional states has been termed emotional self-awareness (ESA).
Possessing ESA has been hypothesized to predict symptomology in mental illness. Selfmonitoring is considered to be one of the first phases of self-regulated behavior (Rafferty
2010). Increasing awareness of emotions is an essential step in training individuals to
change their cognitions, beliefs, and schemas (Kauer et al., 2012). Students who learn to
utilize self-monitoring strategies efficiently can potentially manage a variety of behaviors
(Walker & Shinn, 2002). Additionally, students who efficiently use processes such as
self-monitoring typically have higher levels of self-efficacy, motivation, and educational
achievement (Zimmerman, 2002). Moreover, engaging in SM and practicing ESA has
been correlated with more appropriate help-seeking behaviors (Newman, 2002). Learning
how to use self- monitoring strategies effectively allows youth to manage a variety of
behaviors and emotions (Cooper et al., 2007). This is true not only for typically
developing peers, but also for students with cognitive disabilities.
Specific self-monitoring strategies. Specific SM strategies have been utilized for
the treatment of anxiety. For example, both event and interval recordings are commonly
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used for self-monitoring panic and anxiety. An interval recording strategy involves
observing whether a behavior occurs or does not occur during specified time periods.
Once the length of an observation session is identified, the time is broken down into
smaller intervals that are all equal in length (Craske, Michelle, Jennie & Tsao, 1999).
Event recording is a process for documenting the number of times a behavior occurs. An
observer using event recording makes a tally mark or documents in some way each time a
student engages in a target behavior. The observer also records the time period at which
the behavior is being observed.
Event recording is tied to data regarding a particular situation or event, such as
test anxiety. For each anxious event, students recorded the location, time of day,
behavioral response, and degree of distress, using a self-assessment procedure. This
procedure is highly useful for situations and specific instances such as phobias (Beidel,
Neal, & Lederer, 1991). Manualized CBT programs for anxiety frequently ask
participants to rate their systematic units of distress (SUD), which quantifies feelings of
distress and can be a marker of progress.
Interval recording is the most common method for self-monitoring for generalized
anxiety disorder, given the chronic nature of worry and anxiety that characterizes this
disorder. A version of momentary time sampling is common to self-monitoring the
severity of panic and anxiety (Craske et al., 1999). For example, Hiebert and Fox (1981)
instructed students and volunteer participants to record 0-100 ratings of subjective
distress every waking hour for one week. Barlow et al. (1989) asked clients with panic
disorder to record their daily anxiety levels (0-8-point scale) at four specified times
during the day. Other researchers, such as Borkovec, Grayson, and Cooper (1978),
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required college students experiencing stress to complete daily records for six weeks,
each night. Using self-monitoring as a treatment for anxiety has resulted in significant
declines in both the percentage and severity of tension (Craske et al., 1999).
Researchers have also found that handheld devices offer a particular advantage
for momentary time sampling in that mechanized prompts to enter data at specific points
in time may preclude the delay in self-monitoring that probably occurs otherwise (Craske
et al., 1999).
Using SM to promote ESA may also provide a suitable framework for initial
intervention programs by supporting students in becoming aware of their emotions as a
prerequisite for learning more adaptive coping strategies (Kauer et al., 2012). Moreover,
self-monitoring strategies can be differentiated to meet the needs of students. They are
typically less invasive (Fantuzzo, Polite, Cook, & Quinn, 1988) and potentially more
effective than those administered by an adult such as a teacher (DuPaul & Stoner, 2002).
Technology in self-monitoring. Studies utilizing mobile phone applications for
self-monitoring found that they increased positive mood and coping strategies while
decreasing negative mood in individuals with stress (Kauer et al., 2012). Additionally,
participants in this and similar research increased their ESA and were able to internalize
the questions and therapies used in the mobile programs to treat internalizing disorders
(Kauer et al., 2012). For example, Kauer et al. (2012) examined self-monitoring using
mobile phones for mild or moderate mental health concerns related to mood and stress
with a sample of 114, 14 - 24-year-olds. The randomized control trial indicated that selfmonitoring increases ESA and can decrease symptoms of internalizing disorders. These
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results suggest that mobile phone self-monitoring programs may be an ideal first-step
intervention for internalizing disorders.
Although self-monitoring has shown utility as an intervention for internalizing
disorders, students often need assistance to initially begin to self-monitor their emotions,
thoughts, and behaviors (Flannery-Schroeder & Lamb, 2009). It may be the case that
wearable technology such as a heart rate monitor can be applied as an effective initial
self-monitoring technique. Using the heart rate alarm function could serve as a prompt in
event recording to notice the environment and circumstances as well as correlate SUD
feelings, emotions, and heart rate. The device may also have the capacity to assist in
allowing students to directly recognize distress and immediately employ self-regulation
techniques to normalize heart rate, emotions, and potentially anxiety.
The ultimate goal of recognizing one's emotions is paramount; however, external
prompting is an intermittent step that allows for the scaffolding of this behavior (Shapiro
& Kratochwill, 2000). An external prompt such as a high heart rate alarm can serve as a
teaching tool to signal awareness and prompt remedial behavior.
New technologies and innovations are offering treatment alternatives that utilize
wearable technology, biofeedback, and smartphones. The ubiquity, availability, and
cross-cultural acceptance of these interventions allow them to traverse traditional
boundaries to treatment such as cost, accessibility, time commitment, and negative stigma
(Dennis & O’Toole, 2014). SMHRB could be a tool that allows users to effectively
intervene when experiencing moderate symptoms of anxiety in a way that is least
restrictive and/or could be used as an effective adjunct to more traditional therapy.
The Influence of Biofeedback on Anxiety
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Biofeedback includes utilizing various biomarkers, which can consist of brain
activity, blood pressure, muscle tension, heart rate, skin temperature and sweat gland
activity (Ratanasiripong, Sverduk, Prince, & Hayashino, 2012). When examining heart
rate as a marker of reactivity, anxious and non-anxious individuals initially respond
similarly to environmental stressors with temporary increases in beats per minute (BPM)
of approximately 10 (Stewart, Buffett-Jerrott, & Kokaram., 2001). Although BPM is a
crucial marker of normal acute environmental stress, the measure that distinguishes
between those who struggle with chronic stress and anxiety and those who do not is the
rate at which HR is returned to its resting state after experiencing a stressor. Those who
experience a stressor and can more quickly recover their heart rate to a resting state
exhibit higher heart rate variability (HRV). HRV is negatively correlated with overall
stress level. More precisely, HRV is the variation in the time interval between heartbeats.
It is measured by the variation in the beat-to-beat interval (Ratanasiripong et al., 2004).
Moreover, many studies have found that the relationship between HR and anxiety is bidirectional, indicating that interventions that promote more effective cardiac control can
facilitate improved emotional regulation and anxiety reduction (McKenna, Gallagher,
Forbes, & Ibeziako, 2015; Ratanasiripong et al., 2004; Quintanna et al., 2012; Vitasari et
al., 2011). Vitasari et al. (2011) used biofeedback training to help students prepare
themselves mentally and physically for anxiety. Their biofeedback training program
focused on quickly alleviating the increase in beats-per-minute psychophysiological
arousal associated with stress and anxiety. Thirty-five university students participated in
HR biofeedback training in the research laboratory. The results showed a significant
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decrease in beats-per-minute mean scores after BPM biofeedback training, even though
the participants were not permitted to use the devices outside of the lab.
Biofeedback and Heart Rate Monitoring as an Intervention
Recent technological trends in HR biofeedback. Tracking fitness has become a
significant part of popular culture. There are many ways we can now track fitness. There
are applications such as “My Fitness Pal” that allow us to track our calorie consumption.
These applications can combine with a “fitness tracker,” often a wrist-worn device for
monitoring and tracking health, and fitness-related metrics, such as distance traveled
walking or running, heartbeat, and quality of sleep. The latest iteration of heart rate
trackers has a more comfortable design, compared to older heart rate detection devices
that were expensive, bulky, and required the use of a chest strap. The ability to measure
HR, activity, and sleep, and store this data has not been immediately, directly, and
discreetly available to consumers until very recently. Its potential for use with monitoring
and understanding anxiety is growing.
How biofeedback works. Biofeedback has been used to support relaxation and
aid in the reduction of the body's sympathetic responses to anxiety-provoking stimuli
(Prinsloo et al., 2013). Ratanasiripong et al. (2012) conceptualize biofeedback's impact as
a three-step process involving awareness of the physiological response, controlling their
response, and generalizing the response to daily life. Recognition of the physiological
response is attained through the use of sensors. These sensors relay information to a
smartphone or the built-in display on the wrist-worn HR tracker which provides timely,
functional feedback to the user. The feedback assists users in associating awareness of
body feelings with measured physiological indicators affecting their level of arousal. As
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users gain awareness, they can use relaxation techniques to reduce arousal and more
effectively control their autonomic responses to anxiety-provoking stimuli.
Using these methods outside of a therapeutic or research setting to implement real
change is perhaps one of the most substantial hurdles to overcome. The ultimate goal of
biofeedback is for the individual to be able to recognize physiological symptoms of
arousal and be able to eventually implement interventions without the use of the
biofeedback technology (McKenna, Gallagher, Forbes, & Ibeziako, 2015).
Research supporting Heart Rate Biofeedback. Turner et al. (2014) studied the
effectiveness of combining HR biofeedback with didactic instruction for students
enrolled in a university stress management course. His results showed significant
decreases in anxiety. The participants were randomly assigned to 2 groups, treatment and
control, for four weeks. They measured pre- and post-data using the Beck Anxiety
Inventory (BAI) and found significant results with a .77 effect size.
Several studies have demonstrated that biofeedback is superior to controls in
studies of HRV (Ratanasiripong et al., 2012; Reiner, 2008). Reiner examined the clinical
usefulness of HRV with 24 subjects. He reported 75% of participants using HRV found it
reduced their stress levels. 80% reported increased relaxation. 73-77% of study
participants found HRV-biofeedback more helpful than breathing, yoga, and meditation
(Reiner, 2008). Although a small pilot study, this is a strong representation in that HRVBiofeedback was found more potent than three well-documented intervention techniques.
Moreover, in a study of college-age students, results showed a significantly
greater reduction in anxiety when HRV was added to weekly counseling. Thirty
participants were randomly assigned to a treatment or control group. Both groups utilized
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identical weekly counseling; however, the treatment group added HRV-biofeedback
measures as an adjunct. While both intervention groups yielded a large effect size, the
added effect of introducing HRV-biofeedback yielded a .77 d effect size over the
counseling group (Ratanasiripong et al., 2012).
Potentially, the most convincing evidence in support of further examination of
heart rate biofeedback comes from one of the few, and potentially only, meta-analyses on
the topic conducted by Goessl, Curtiss and Hofmann (2017). They included 24 studies
totaling 484 participants (ages 18-63) who received HRV biofeedback training for stress
and anxiety. A random-effects meta-analysis resulted in pre-post within-group effect size
(Hedges' g) of 0.81. Additionally, a between-groups analysis comparing biofeedback to a
control condition yielded Hedges' g = 0.83. The authors concluded that HRV biofeedback
training is associated with a large reduction in self-reported stress and anxiety. They also
maintain the intervention offers a promising approach for treating stress and anxiety with
wearable devices.
HR-V vs. HR-BPM biofeedback. Heart Rate Variability (HRV) has been used as
a global measure of cardiac health and an overall measure of autonomic responsiveness
to stress and anxiety (Quintana et al. 2012; Ratanasiripong et al., 2004). Measurement of
HRV includes BPM in its calculation and uses a relatively complex algorithm compared
to the simple tracking of BPM (calculations on HR & HRV). In contrast with heart rate
(BPM), HRV is the variation in the time interval between heartbeats and has the potential
to distinguish between typical individuals those who struggle with chronic stress
(Ratanasiripong et al., 2004).
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Although HRV has been used in interventions, it is a more global measurement of
stress. In contrast, a beats-per-minute (BPM) heart rate biofeedback intervention is
immediate and can more easily influenced in real time. Vitasari et al. (2011) found that a
HR BPM intervention was useful to measure and reduce stressor-induced elevated heart
rate more quickly and was also effective in overall long-term anxiety reduction. Training
individuals to recognize and more quickly reduce their heart rate (BPM) consistently, in
response to a stressor, could have beneficial effects on HRV (increase) and reduce overall
stress and anxiety (Vitasari et al., 2011)

73

Appendix B
Measures
Clinically Useful Anxiety Outcome Scale (CUXOS)
The Clinically Useful Anxiety Outcome Scale (CUXOS) is a brief, 20-item selfreport measure designed to assess the severity of anxiety symptoms in adults with a
diagnosed Anxiety disorder or Depression (D’Avanzato et al., 2013; Zimmerman,
Chelminski, Young, & Dalrymple, 2010). The CUXOS can be used as a screening tool or
to monitor and evaluate symptom changes over the course of treatment, as it is sensitive
to change (Beidas et al., 2015).
Developed in 2010, the CUXOS item content is based on the DSM-IIIR and DSM-IV descriptions of Generalized Anxiety Disorder and Panic Disorder
(Zimmerman et al., 2010). The items are derived from the Hamilton Rating Scale for
Anxiety (1959), whilst the structure of the measure is based on the Clinically Useful
Depression Outcome Scale (2008). The CUXOS is comprised of two subscales: the
psychic anxiety subscale, consisting of 6 items (“I felt scared”), and the somatic anxiety
subscale containing 14 items (“I was sweating”). Each item is rated on a Likert-type scale
from zero (“not at all true”) to four (“almost always true”), with total scores ranging from
zero to 80 (<10 non-anxious; 11-20 minimal anxiety; 21-30 mild anxiety; 31-40 moderate
anxiety; 41+ severe anxiety). On average, clients completed the measure within two
minutes and clinicians scored the scale within 15 seconds (Zimmerman et al., 2010). The
efficient nature of this measure is an advantage when considering using it as a screening
tool or to monitor symptom change over time.
The CUXOS’ solid psychometric properties are also an advantage. The initial
validity study included 963 patients, 556 with a diagnosed non-comorbid anxiety disorder
and 407 with no current anxiety disorder (Zimmerman et al., 2010). The study
demonstrated strong internal consistency for the total scale (Cronbach α = 0.95) and each
subscale (α = 0.90 for the psychic anxiety subscale, and α = 0.93 for the somatic anxiety
subscale). The test re-test reliability of the total scale was also strong (r=0.90).
In terms of convergent and divergent validity, the CUXOS correlated more highly
with other measures of anxiety (median r=0.54) than with scales measuring other
symptom domains (median r=0.32). The CUXOS’ ability to discriminate between
severity levels was also investigated via an analysis of variance conducted with the Social
Avoidance and Distress Scale (SADS) severity ratings in relation to the CUXOS’ ratings.
Higher SADS severity ratings correlated significantly with higher CUXOS ratings of
severity.
Whilst the psychometric properties reported in the Zimmerman et al. (2010) study
are promising, little research has been conducted on different demographic features and
varied clinical populations. At this stage there is only one other validity study concerning
the CUXOS. Jeon et al. (2017) conducted a study with 838 psychiatric outpatients during
intake, using a Korean adaptation of the CUXOS. The study found similar psychometric
properties as reported by the original study, with a high internal consistency (Cronbach α
= 0.90) and a test re-test reliability of r=0.74. Jeon et al. also found that the CUXOS was
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more highly correlated with other measures of anxiety (mean r= 0.74) than with measures
of the other symptom domains (mean r= 0.53).
Based on the current literature, the CUXOS is a valid and reliable brief
assessment tool. The CUXOS can be readily incorporated into clinical practice, given the
efficiency and ease of administering and scoring. However, there are limitations. The
scale is not extensively researched and the impact of individual difference factors has not
been explored rigorously. Additionally, clinicians should be mindful that item content is
based on the DSM-III-R and DSM-IV definitions of anxiety disorders and some symptoms
of distress may be underreported if triggers are being avoided by the client, e.g. phobic
objects may not have been encountered that week.
DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure—Adult
The DSM-5 provides cross-cutting symptom measures (CCSMs), which are
utilized for consideration across diagnostic symptoms. Level 1 is concise, including 1–4
items on each domain, while Level 2 is more comprehensive, including a measure for
each domain. The Level 1 CCSMs are more general measures that include symptoms
across domains consistent with common diagnostic categories (e.g., depression, anxiety)
and assess a wider scope of time (i.e., two weeks). The Level 1 CCSMs are designed for
adults to complete as a self-report. The Level 1 measure contains 23 items across 13
domains.
The Level 2 CCSMs are utilized after finding threshold scores from Level 1
measures. Level 2 measures contain a more detailed symptom investigation that can help
with diagnosis and treatment, including assessment of a shorter time period (i.e., 7 days).
Level 2 measures include such symptoms as depression, anger, mania, anxiety, somatic
symptoms, sleep disturbance, repetitive thoughts and behaviors, substance abuse,
inattention, and irritability. Certain measures address how often the individual has been
bothered by a symptom within a time period of 7 days, and others ask the individual to
pick a statement in a cluster that best represents the way he or she has been feeling within
the past 7 days. Similar to the Level 1 measures, adults and children/adolescents between
the ages of 11 and 17 may complete a self-report version; these measures can be used at
the early stages of treatment and throughout the treatment process (American Psychiatric
Association, 2013).
Evidence supports the use of the DSM-5 Cross Cutting measures with a college
population. Bravo et al. (2018) conclude that the DSM-5 CCM have acceptable internal
consistency across multi-item DSM–5 domains and moderate to strong correlations
among domains (internal validity). Further, several DSM–5 domains were positively
associated with longer, validated measures of the same mental health construct and had
similar strengths of associations with substance use outcomes compared to longer
measures of the same construct (convergent validity), a large, diverse sample of nontreatment-seeking college/university students. This conclusion was based on data from
7,217 college students recruited from 10 universities in 10 different states across the
United States. The authors assert the DSM–5 Level 1 measure is a viable tool for
identifying and addressing psychopathology in college students (Bravo, VillarosaHurlocker, Pearson., 2018).
The DSM-5 provides cross-cutting symptom measures (CCSMs), which are
utilized for consideration across diagnostic symptoms. Level 1 is concise, including 1–4
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items on each domain, while Level 2 is more comprehensive, including a measure for
each domain. The Level 1 CCSMs are more general measures that include symptoms
across domains consistent with common diagnostic categories (e.g., depression, anxiety)
and assess a wider scope of time (i.e., two weeks). The Level 1 CCSMs are designed for
adults (23 items across 13 domains). Adults may complete self-report versions.
The Level 2 CCSMs are utilized after finding threshold scores from Level 1
measures. Level 2 measures contain more detailed symptom investigations that can help
with diagnosis and treatment, including assessment of a shorter time period (i.e., 7 days).
Level 2 measures include such symptoms as depression, anger, mania, anxiety, somatic
symptoms, sleep disturbance, repetitive thoughts and behaviors, substance abuse,
inattention, and irritability. Certain measures address how often the individual has been
bothered by a symptom within a time period of 7 days, and others ask the individual to
pick a statement in a cluster that best represents the way he or she has been feeling within
the past 7 days. Similar to the Level 1 measures, adults and children/adolescents between
the ages of 11 and 17 may complete a self-report version; these measures can be used at
the early stages of treatment and throughout the treatment process (American Psychiatric
Association, 2013).
Instructions to Clinicians
Participants will complete the first general, Level 1 DSM-CCM measure in
person using paper and pencil. The DSM-5 Level 1 Cross-Cutting Symptom Measure is a
self or informant-rated measure that assesses mental health domains that are important
across psychiatric diagnoses. It is intended to help clinicians identify additional areas of
inquiry that may have a significant impact on the individual's treatment and prognosis.
Also, the measure may be used to track changes in the individual's symptom presentation
over time.
This adult version of the measure consists of 23 questions that assess 13
psychiatric domains, including depression, anger, mania, anxiety, somatic symptoms,
suicidal ideation, psychosis, sleep problems, memory, repetitive thoughts and behaviors,
dissociation, personality functioning and substance use. Each item probes how much (or
how often) the individual has been bothered by the specific symptom during the past two
weeks. The measure was found to be clinically useful and to have good test-retest
reliability in the DSM-5 Field Trials that were conducted on adult clinical samples across
the United States and Canada.
Scoring and Interpretation
The investigator will score the general, Level 1 cross cutting measure
immediately to determine if a second, Level 2 disorder-specific measure is needed. Each
item on the measure is rated on a 5-point scale (0=none or not at all; 1=slight or rare, less
than a day or two; 2=mild or several days; 3=moderate or more than half the days; and
4=severe or nearly every day). The score on each item within a domain should be
reviewed. Because additional inquiry is based on the highest score on any item within a
domain, the clinician is asked to indicate that score in the “Highest Domain Score”
column.
A rating of mild (i.e., 2) or greater on any item within a domain (except for
substance use, suicidal ideation, and psychosis) will be used to indicate a required follow
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up with a disorder specific Level 2 cross cutting measure. For substance use, suicidal
ideation, and psychosis, a rating of slight (i.e., 1) or greater on any item within the
domain may serve as a guide for additional inquiry and follow-up to determine if a more
detailed assessment is needed (suicide will require a risk assessment, see Emergency
Protocols in Appendix D).
Scoring procedures are unique for each of the Level 2, disorder-specific measures.
Each procedure will be followed explicitly, and participants will be offered referrals if,
after scoring, individuals indicate mild or greater in any disorder other than anxiety. Each
disorder-specific Level 2 screen provides individual guidance as to what meets the mark
of mild symptom severity. The link to the measure can be accessed here:
https://www.psychiatry.org/psychiatrists/practice/dsm/educational-resources/assessmentmeasures
Procedures used with Measures
CUXOS. The repeated measures design included ten total assessment points,
including the pre-and post-measures using the CUXOS which was primarily remotely
administered using a survey link (Google Form) and delivered by text message on
Sunday evenings. With the exception of the initial baseline CUXOS measure, the preintervention and post-intervention data from the preplanned CUXOS measure was
obtained on Sunday evenings each week via Google Form. The CUXOS measurements
obtained on Sunday at the end of each HRV of the participant was also be measured at
three-time intervals during the study (First meeting-baseline, pre-intervention, and postintervention).
Final survey. Additionally, a qualitative style survey was administered using
Google Forms or in person (based on convenience for participant and their response to
times offered by the researcher or filling out a link) during the final assessment of the
CUXOS and HRV measures. The survey obtained information about the subjective
usefulness of the device and intervention. Information was collected to assess the
likelihood that future users would find this intervention useful. Sample questions from
the survey include: Was the device easy to use? Please explain. Was the device difficult
to use? Explain. Did you feel the SMHRB intervention was helpful? Explain. Did you
feel that the SMHRB intervention was not helpful or would not help you in the future?
Explain. Would you continue to use it? Explain. Is there anything else you want to tell me
about the experience?
While automatically collected electronic data indicating adherence to fidelity
protocols provides the most reliable information, self-reports are valid and recommended
methods to collect treatment fidelity data for mental health interventions (Belleg et al.,
2014).
Biofeedback measures and devices. The Self-Monitoring Heart Rate
Biofeedback (SMHRB) includes the use of Maximum HR alerts used to alert users of the
presence of a raised HR, a symptom of anxiety. SMHRB may also assist with relaxation
breathing by guiding users to reduce HR more effectively with guided HR biofeedback.
The device used to measure HR-BPM featured a wrist-based optical heart rate monitor
(The Mio Alpha 2) that can measure heart rate continuously as well as a feature to alert
the user when their heart rate reaches a certain threshold. In general, wrist-based heart
rate monitors have shown reliability and accuracy. The percentage of error measured
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across a variety of devices is small (range: 1–9% < 5bpm) (Wallen et al., 2016). The
wrist-based feature is essential, as the usability and social validity of the intervention rest
on this premise. The Mio Alpha and Polar HR devices are examples of devices that have
the requisite features and have shown good accuracy, according to Wallen et al. (2016).
In order to establish an accurate resting heart rate and max heart rate, a systematic
procedure (See Appendix B) was followed (Palatini 2009). The average resting heart rate
for each participant served as a target for the SMHRB intervention. Participants
experiencing anxiety were told to use SMHRB to initiate relaxation and attempt to lower
heart rate and reduce anxiety symptoms. Furthermore, setting a maximum HR threshold
for participants signaled that their heart rate was elevated and that the user may be
experiencing anxiety, which would prompt them to gain more insight into ESA and
prompt the use of SMHRB.
In the intervention phase of treatment, participants demonstrated the ability to use
relaxation breathing to reduce HR in the initial training session. For example, the
participants followed the relaxation breathing techniques and initiated these techniques to
verify they feel a sense of relaxation from relaxation breathing or a reduction in HR of
three-five beats per minute in response to relaxation breathing (See Appendix D for more
details about the intervention and training).
HRV was obtained by using a more accurate chest strap HR monitor. This was
required to take baseline, pre- and post- measures of HRV. HRV was measured for each
participant at baseline, pre- and post-intervention using the average of three trials for each
measurement period. HRV is measured by analyzing the time between heartbeats. This
measure is used to gain another aspect of emotional distress. HRV has been shown to
correlate with anxiety and has been used consistently in a variety of studies as a measure
of overall stress and psychological functioning (Sharma, Balhara, Sagar, Deepak, &
Mehta, 2011). The HRV measure is a supplemental comparison to the final post-CUXOS
measures and aided in determining effectiveness of the intervention.
Calculating resting HR. Resting heart rate is an easily measurable
cardiovascular parameter but is subject to high variability. There are many sources of
variability, including the resting period before measurement, environmental conditions,
method of measurement (pulse palpation versus electrocardiogram), number of readings,
duration of measurement, position of the body, and nature of the observer.
According to the Consensus Panel of the European Society of Hypertension, the
following information should be provided in studies reporting heart rate data: (i) resting
period before measurement; (ii) environmental conditions; (iii) method of measurement;
(iv) number of measurements; (v) duration of measurement; (vi) body position; and (vii)
nature of the observer (Palatini, 2009).
Electrocardiographic (ECG) recording is the most precise method of heart rate
measurement and is routinely carried out in many clinical settings. However, use of
electrocardiography implies greater financial costs, and it is not known whether increased
measurement precision actually translates into more meaningful data. According to
Houser et al. (2013), measurements between commercial electronic devices and ECG are
highly correlated (R>0.9) and provide similar information. For this reason,
electrocardiographic measurement is not required for the measurement of resting heart
rate, even in research.
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Electronic pulse meters consist of two parts: a transmitter placed over the artery
and a receiver for display. A digital system is usually accurate to within 3-4 bpm of an
electrocardiographic recording (Wallen et al., 2009). The Polar HR monitor selected for
this study has been shown to be accurate to within 1 beat per minute of an
electrocardiogram (Wallen et al., 2009).
In an attempt to minimize the effects of confounding factors, the process of
measuring HRV at baseline was standardized. Participants were asked about exercise,
alcohol, nicotine and coffee intake. They were instructed to avoid these activities in the
hours preceding measurement, and they were asked if they complied before being
measured. They were also asked to abstain in the hours preceding the final HRV
measurement at the conclusion of the study. No readings required postponement, as was
recommend if participants answered in the affirmative (Palatini, 2009). Readings were
taken using the monitor while the patient was comfortably seated in a chair with legs
uncrossed. The room was at a comfortable temperature and background noises were
limited. The patient was asked to refrain from talking during the procedure, and at least 5
minutes elapsed in this setting before the first reading was taken. A quiet, private room in
the instructor suite on the URI campus was reserved for these purposes as well as to
maintain confidentiality. If the student was taking any medications, we asked if they had
been taking them consistently through all measures in order to ensure continuity of
results.
Prior to administering any measurements, the participant was asked to rest for at
least 5 minutes. However, if participants reported feeling highly anxious in the moment
or had disclosed a pronounced “white-coat reaction” (medical anxiety), a longer waiting
period was employed. The duration of measurement ranged from 15 seconds to 1 minute
in different studies. The aforementioned European consensus panel recommends 30
seconds to obtain a reliable estimate of heart rate, and this timeframe (30 seconds) was
adopted as a consistent waiting period to measure resting HR for this study. Two
measurements have been shown to be sufficient for a reliable estimate of resting heart
rate in most patients (Palatini, 2009). The Polar H10 Heart Rate Monitor was used as the
device to measure the baseline HR following the aforementioned procedures.
For comparison purposes, the following guideline values were utilized: The
average resting heart rate of adults can range from 60-100 BPM. The Centers for Disease
Control (CDC) estimate that the average resting heart rate for the adolescent population
(age 16-19) is 75 BPM. In typical adolescents and adults, HR-BPM has been shown to
fall at the following values (5th percentile = 54) (25th= 64)(50th=73)(75th= 82)(95th= 95)
(Ostchega et al., 2011).
HRV calculation. All HRV measurements were obtained by the Polar strap worn
device and taken at pre- and post-study assessments. One of the standard measures used
for calculating HRV is SDNN, which stands for standard deviation of the inter-beat
intervals of normal sinus beats. SDNN and measures of HRV have been hypothesized to
be associated with the strength of the parasympathetic component of the autonomic
system. SDNN is considered one of the most relevant and accurate measures of the
autonomic nervous system. The SDNN is the "gold standard" for medical stratification of
cardiac risk. SDNN values predict both morbidity and mortality. Based on 24-hour
monitoring, patients with SDNN values below 50 ms are classified as unhealthy, 50–
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100 ms have compromised health, and above 100 ms are healthy (Shaffer and Ginsberg,
2017). SDNN will be automatically calculated on the Polar application.
HRV is measured using a chest belt or photo-plethysmography to measure HRV,
and both have been shown to provide reliable HRV measurement (>.98r ) compared to
ECG (Flatt and Esco, 2013).
For accuracy, students were asked not to participate in sports or any activity more
rigorous than walking for 12 hours before the HRV measurement. Participants used a
chest strap and sat and waited five minutes after it was put on to get an accurate HRV
measure. All the standard procedures previously mentioned for obtaining heart rate were
followed for HRV, with the addition of a chest strap and recommendations for reduction
of physical activity before the assessment.
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Appendix C
Ethics, Emergency Procedures and Psychoeducation
Ethics/Informed Consent
The research has been presented and approved by the Institutional Review Board
(IRB). One of the protections for the subjects is a clear description of research protocols
and procedures. Research participants’ information was protected in an encrypted,
password-secured protected file. Another benefit to participants includes psychoeducation with respect to the physiological aspects of anxiety. Additional benefits include
practice with coping mechanisms (relaxation breathing); potential reduction of symptoms
of anxiety; and a fitness tracker/ heart rate monitor.
The URI students were free to participate without penalty or coercion and were
allowed to opt out at any time. Prior to obtaining informed consent, participants were
provided an in-depth description and full disclosure of procedures. Although unlikely,
participants who did not see improvement could have become frustrated with their
participation. Students were made aware that they could opt for a referral for counseling
at any point during the study.
Emergency Procedures
In the extremely unlikely event that a participant disclosed that they may be at
risk of self-harm, a more thorough risk assessment (SAFE-T) would have been
conducted. SAFE-T includes questions and guidance to assess any ideation, intention,
means or a plan to harm oneself. The SAFE-T plan could be implemented by the
investigator who has training on risk assessments and experience conducting them. See
SAFE-T plan at this website:
https://www.integration.samhsa.gov/images/res/SAFE_T.pdf. If any of the essential risk
questions were answered in the affirmative, or if the student felt unsafe, campus
emergency personnel would have been alerted, and the student would not be left alone. If
there is was no immediate danger but the potential participant endorsed symptoms of
moderate depression or other symptoms of disorders as indicated on the DSM-5
measures, a referral for counseling would have been provided.
Psychoeducation Protocol
Participants who did not meet inclusion criteria or were excluded were provided
guidance for how to access psychoeducation media after they had been given measures
determining their eligibility status. This was accomplished by sending them an email and
instructions to access a website on their own or in the form of a brief guided tour through
a comprehensive website on anxiety in person at designated times. The in-person option
was offered to interested individuals; however, if in-person attendance was not possible,
web options described above were offered. The website includes an overview of typical
anxiety presentations, normalization of anxiety, and possible uses of coping mechanisms.
A short video on the same webpage can be viewed so participants have coping strategies
modeled for them. Those who were not included in the study were encouraged to
download the accompanying mobile app that is associated with the page that may help
them.
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Ineligible participants were extended a referral for counseling if their anxiety
symptoms were severe (anxiety above 41 on the CUXOS) and/or their symptoms were
indicative of another disorder as described previously in exclusion criteria. Students were
given a global screener, DSM- 5 Cross-Cutting Symptom Measure (DSM-5 CCSM, in
person, paper and pencil version), (see Appendix B for administration instructions) to
determine the potential for other causal factors of distress besides symptoms of anxiety.
The DSM-5 CCSM is a global screening (Level 1) measure that indicates if participants
should be screened further for specific disorders. For example, while the screener has
several disorder categories, if a participant endorses any question in a depression
category on the global (Level 1) screener that indicates the potential presence of
depression then a more specific (Level 2) depression evaluation screening was conducted.
Participants who indicated mild symptoms or greater on the second, more-specific
disorder measure would be extended a referral and excluded from the study. If
participants endorsed symptoms of a disorder (other than anxiety) on the first, general
Level 1 screen and did not indicate mild symptoms of the disorder on the more
comprehensive level 2 screen they were still eligible for the study. Once participants
were administered the CUXOS and DSM-5 CCSM, the items were scored immediately,
and students learned of their eligibility status prior to leaving the initial assessment
meeting.
Scoring procedures for DSM-5 Screening tools (individual domain screeners have their
own scoring): https://www.psychiatry.org/psychiatrists/practice/dsm/educationalresources/assessment-measures
Psychoeducation Website:
https://www.anxietybc.com/parenting/generalized-anxiety-disord
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Appendix D
Relaxation Breathing Training & Procedures
Participants were asked to follow instructions below to implement relaxation
breathing when they receive a maximum HR alert (excluding physical activity, including
walking). The procedure to implement calm breathing was also accompanied by an audio
guide that was played for participants. During this initial introduction to the audio, they
practiced for a short time (1 minute and 43 seconds). This was repeated as needed until
participants indicated they could undertake this protocol on their own and could reduce
HR by 3-5 BPM. If they needed more practice time, that was allowed by the researcher.
The website with accompanying audio is provided here:
https://www.anxietybc.com/adults/calm-breathing
Furthermore, once a HR alert had occurred a participant was to engage in further
self-monitoring which included HR biofeedback using the wrist-worn digital HR monitor
display. Although HR monitoring is used during relaxation breathing (altering breaths to
ensure a reduction in HR), it may also act as an SM intervention by increasing
physiological awareness while allowing more efficient reduction in HR. The combination
of the HR alert and relaxation breathing enhanced by HR biofeedback comprises the
SMHRB intervention package. Relaxation breathing to initially train individuals to
reduce HR may help to confirm they are executing the breathing in an effective way to
relax and improve symptoms.
Once participants demonstrated in training that they could perform relaxation
breathing, by showing a small reduction in HR (3- 5 bpm) or indicating they felt more
relaxed after breathing, they may no longer needed to monitor their HR after a maximum
HR alert. Relaxation breathing after a HR alert without viewing the HR display may be
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enough for participants in-vivo. Participants could still confirm their HR is below the
Max HR threshold when the red light has changed to green.
How to Do Calm Breathing
Calm breathing involves taking smooth, slow and regular breaths. It is best to 'take the
weight' off your shoulders by supporting your arms on the side-arms of a chair, or on
your lap.
1. Take a slow breath in through the nose, place your hand on your lower abdomen and
feel it rise with the in breath.
2. Hold this breath at the end of the inhale for approximately 3-4 seconds.
3. Exhale slowly through the mouth (for about 5-7 seconds).
4. Wait a few seconds before taking another breath.
5. During your breathing, watch the HR display on your monitor confirm that your
breathing is reducing HR-BPM. If HR-BPM is not being reduced, alter breathing by
lengthening outbreaths by a second or 2. Find the rhythm that's comfortable and
reduces HR for you.
6. About 6-8 breathing cycles per minute are often helpful to decrease anxiety, but find
your own comfortable breathing rhythm. These cycles regulate the amount of
oxygen you take in so that you do not experience the fainting, tingling and giddy
sensations that are sometimes associated with over-breathing*.
*Over-breathing is similar to hyperventilating. Over-breathing involves taking quick shallow breaths and essentially
taking in excess air which depletes valuable CO2, an important regulator of many functions in the body. This behavior
is often associated with anxiety and occurs more frequently when one is anxious.
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Appendix E
Participant Daily Text Message Questions
Afternoon and Evening Daily Text Message Questions:
1. Did you wear the monitor device (AM) or (PM)?
1. If you wore the device for more than 75 % of this period, respond
yes.
2. How many times did the device alert you?
3. Of the alerts you counted above, how many of those times did you feel
anxious?
4. Out of the times you were alerted and felt anxious how many times did
you engage in relaxation breathing?
5. Were there any times you did relaxation breathing w/o an alert? If yes,
how many sessions?
*AM Text period (Awake – 3pm), PM Text period (3pm – 10 pm)
•
•

Anxious means: Definition: a feeling of worry, nervousness, or unease,
typically about an imminent event or something with an uncertain
outcome.
If you experience two or more of the following symptoms simultaneously,
you may likely be experiencing anxiety: feeling physically tense or
'wound up'; a sort of frightened feeling like 'butterflies' in the stomach; a
sort of frightened feeling as if something awful is about to happen;
restlessness as if you have to be on the move; worrying thoughts going
through your mind; you can’t sit at ease and feel relaxed; you get sudden
feelings of panic; feeling irritable; having trouble concentrating or
focusing on what you’re doing (Based on the Hospital Anxiety Scale,
adapted for use in describing momentary feelings).
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Appendix F
Open-Ended Study Conclusion Questionnaire Responses
Participant#
Q1
1

2
3

4

5
6
7

Open Ended Questions & Participant Responses
Was the intervention easy to use? Please explain.
I felt as though the intervention was very simple to use. I struggled at first using the watch and
figuring out all of the basic functions it had. I always seemed to turn on some sort of workout or
fitness thing and it wouldn’t really turn off until the watch was switched off at the end of the day.
The breathing techniques were extremely simple and not hard to figure out. They were not at all a
challenge even when I found myself having anxiety on the go (library, class, driving, etc.).
Yes, the intervention was easy to use. Once I learned more how to turn it on, turn it off, charge it,
and track my heartbeat, it was much easier to use.
Yes! It was very easy to use it really became a part of my daily routine to charge it at night like my
phones and to answer the survey as much as I could daily. Having it texted to me made it much
easier to remember to fill it out as well as having the app on my phone.
Yes, I would consider the intervention overall easy to use. The device and breathing techniques
were both very easy to learn and it did not interrupt my daily life. The surveys were not time
consuming either, and were very through in their explanations.
Yes, it was easy in the way of recording my heart rate and knowing when it flashed red or green.
The device was not hard to use but it was confusing and at times I couldn’t get it to sync to the
app. I feel like if I knew how to correct this era it would have been easier for me.
It was very easy to use, recording what the heart monitor read twice a day was not difficult at all.
When I saw my heart rate spike, I used the breathing exercises I was taught.

Q2

Was the intervention difficult to use? Please explain.

1

The only thing I struggled with was simply responding to the questions after each time slot. I
found that the time slot always seemed to end while I was in class or in the middle of something
else. Besides that, nothing was too difficult.
It was only difficult to use at the beginning when I was unsure how to track my heart beat after
charging it.
I never had any difficulties using it. There were only a few times it would slip my mind to fill it
out on a busy day but other than that no issues!
The only difficult parts of the intervention were wearing the device at all times. There were several
times like dinners or formal events when I did not want to wear the device and had to remember to
be aware of my heart rate without it and remember to bring it for wearing after.
The heart monitor was hard to use sometimes because the buttons were unclear and hard to push

2
3
4

5
6
7

The difficult part was know how to navigate the watch with the app. At times it would say it was
syncing but nothing else would happen and then I would not be able to use it.
No it was not difficult at all. I sometimes forgot to respond to the daily surveys but that was it.

Q3

Do you feel the intervention was helpful? Explain.

1

I definitely helpful overall. I seemed to be much more relaxed and my overall anxiety seemed to
be decreased. The breathing really seemed to help me calm down especially when my anxiety was
keeping me from doing things like studying or doing homework.
I definitely helpful overall. I seemed to be much more relaxed and my overall anxiety seemed to
be decreased. The breathing really seemed to help me calm down especially when my anxiety was
keeping me from doing things like studying or doing homework.
I found it to be very helpful it helped me be more mindful about my anxiety and taking the time to
try and calm myself down in a different way rather than taking a nap or just staying in bed that
day. It helped me want to try and get through it and see if this could really be something that
worked for me.
I absolutely consider my participation in the study helpful to myself. It increased my awareness of
my heart rate, anxiety and their interrelation. It was helpful to see the quantitative data when I was
anxious and having the goal of lowering it gave me a way to see how well or not I could calm
myself down.
Yes, I felt that my anxiety decreased and the deep breathing brought my heart rate down.
Yes, I started using the breathing exercises more often and even did them with my friend who
suffers from anxiety when she would have panic attacks and they helped her as well. At times I
wouldn’t be anxious and the watch would turn red, which was concerning cause sometimes it
would remain red unless I did the breathing exercises.

2

3

4

5
6
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7

Q4
1

2

3

4
5
6
7

Q5
1

2
3
4
5
6
7

Q6
1

2

3
4

5
6
7

I think it was helpful because seeing my heart rate spike reminded me to take a couple deep
breaths and relax. Also if I was ever feeling anxious the breathing exercises really helped.

Did you feel the SMHRB intervention was not helpful or would not help you in the
future? Explain.
The biggest thing I struggled with was the flashing on the watch. If I was not feeling anxious and
looked down to see the watch flashing red. It would make me feel as though I should be anxious
because my heartrate was up. If the light was either constant or not there at all and there was
another way of being notified when my heartrate was up that would be great. The flashing red light
was like a reminder to “be anxious” and that I need to calm down. In the end it kind of became a
trigger of sorts.
I feel that the SMHRB intervention was definitely helpful. I know that it will help me in the future
when I am stressed about something, I will use the breathing exercises to help me calm down and
focus.
I never felt like it was not helpful. I think it is important to be aware of my heart rate and the
things that may give me more anxiety on a daily basis to see if I can somehow change my day
even a little to avoid that.
I did not feel this way. There were no lasting negative effects from my participation
No, it was very helpful.
N/A
I think it will help me in the future if I ever feel anxious or overwhelmed, I can take a minute to do
the breathing exercise and keep my heart rate down

Do you plan to continue to use the intervention now that the study is completed?
Explain.
I do plan to continue with the breathing for sure. I don’t know if I will continue wearing the watch
as much as a do now. But, I do plan on wearing it on days that I know I will be stressed or anxious,
in order to, help me better manage it.
I do plan to continue to use the intervention. I will not use it every day like I did during the study
but will continue to use it.
I have already continued to use it! I think it is important to keep going with this even without the
survey tracking daily to see if I can make a change for myself even if it is just a slight change.
I do plan to continue practicing the breathing exercises in the future. I may not wear the monitor
all day but plan to monitor my heart rate myself since I now know how to.
Yes, I do deep breathing everyday now even when I don’t see my heart rate
I will probably not use the watch since I have an apple watch already that monitors my activity and
heart rate.
I will definitely keep using the breathing technique if I ever feel anxiety coming on.

Anything else you want to tell me about the experience?
Overall, I definitely enjoyed the experience and thank you for letting me partake. I hope to be
involved in any other studies that you do, if you will have me. If you have any further questions
from me please let me know.
The HRV watch is difficult to track all of the red flashes, but it is better than a watch that alerts
you every time. I tried my best to count all of the red flashes but I might have missed a few.
Overall, my experience with this study was great.
Thank you
I’m glad that I participated. I was not the biggest fan of the color, size and blinking of the watch,
which is why I did not wear it to formal events. Also I feel the blinking red light is not the best
indicator. Seeing the two blinking red lights often made me more anxious when I saw it, more so
than just seeing the number. For some reason seeing the blinking red light made me feel more
anxious if I was not already. Thank you for letting me participate.
Nope! It was very helpful and I plan on doing deep breathing more often!
The reminders were helpful because it made me more aware of when I was anxious and helped me
learn how to better manage it.
It was very helpful in finding ways to relax during stressful times!
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